Professor Lisa K Stamp

2024

Journal - Research Article

Stamp, L. K., Horne, A., Mihov, B., Drake, J., Haslett, J., Chapman, P., Frampton, C., & Dalbeth, N. (2024). Predicting gout flares in people starting allopurinol using the start-low go-slow dose escalation strategy. Arthritis Care & Research. Advance online publication. doi: 10.1002/acr.25376

Dalbeth, N., Te Karu, L., & Stamp, L. K. (2024). Gout and its management. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.16382

Wright, D. F. B., Hishe, H. Z., Stocker, S. L., Dalbeth, N., Horne, A., Drake, J., Haslett, J., Phipps-Green, A. J., Merriman, T. R., & Stamp, L. K. (2024). The development and evaluation of dose-prediction tools for allopurinol therapy (Easy-Allo tools). British Journal of Clinical Pharmacology. Advance online publication. doi: 10.1111/bcp.16005

Chuah, M. H., Leask, M. P., Topless, R. K., Gamble, G. D., Sumpter, N. A., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2024). Interaction of genetic variation at ADH1B and MLXIPL with alcohol consumption for elevated serum urate level and gout among people of European ethnicity. Arthritis Research & Therapy, 26, 45. doi: 10.1186/s13075-024-03279-9

Maher, D., Reeve, E., Hopkins, A., Tan, J. M., Tantiongco, M., Ailabouni, N., … Stamp, L., … Wiese, M. (2024). Comparative risk of gout flares when initiating or escalating various urate-lowering therapy: A systematic review with network meta-analysis. Arthritis Care & Research. Advance online publication. doi: 10.1002/acr.25309

Stamp, L. K., Keating, P., Frampton, C., Barclay, M. L., Fanning, N., Millier, M., Hessian, P. A., & O'Donnell, J. L. (2024). Relationship between adalimumab concentrations, anti-drug antibodies and disease activity in rheumatoid arthritis: A cross-sectional observational study. Journal of Rheumatology, 51(3), 242-249. doi: 10.3899/jrheum.2023-0706

Stamp, L. K., & Dalbeth, N. (2024). Moving urate-lowering therapy in gout beyond guideline recommendations. Seminars in Arthritis & Rheumatism, 65, 152358. doi: 10.1016/j.semarthrit.2023.152358

Christensen, R., Zobbe, K., Nielsen, S. M., Stamp, L. K., Henriksen, M., Overgaard, A. F., … Kristensen, L. E. (2024). Weight loss for patients with gout and concomitant obesity: A proof-of-concept randomized trial. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.42790

Farquhar, H. J., Beckert, L., Edwards, A. L., Matteson, E. L., Frampton, C. M. A., Ganly, E., … Haslett, J., … Stamp, L. K. (2024). Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand: A retrospective cohort study. Seminars in Arthritis & Rheumatism, 64, 152359. doi: 10.1016/j.semarthrit.2023.152359

Journal - Research Other

Stamp, L. K., & Dalbeth, N. (2024). What is allopurinol "failure" and what should we do about it? Journal of Rheumatology. Advance online publication. doi: 10.3899/jrheum.2024-0144

Stamp, L. K., Christensen, R., & Morillon, M. B. (2024). Serum urate as a surrogate outcome for gout flares: Where do we stand today? Gout, Urate, & Crystal Deposition Disease, 2, 70-76. doi: 10.3390/gucdd2010007

Conference Contribution - Published proceedings: Abstract

Tabi-Amponsah, A., Stamp, L., Horne, A., Drake, J., Stewart, S., Gamble, G., … Dalbeth, N. (2024). Analysis of gout remission criteria in a randomised controlled trial of colchicine prophylaxis while initiating urate lowering therapy. International Journal of Rheumatic Diseases, 27(Suppl. 2), O21. doi: 10.1111/1756-185X.15171

Fanning, N., Cadzow, M., Topless, R., Frampton, C., Dalbeth, N., Merriman, T., & Stamp, L. (2024). Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol. International Journal of Rheumatic Diseases, 27(Suppl. 2), O14. doi: 10.1111/1756-185X.15171

Alfeld, K., Barclay, M., Dalrymple-Alford, J., McNeill, R., Frampton, C., Doogue, M., & Stamp, L. (2024). In-patient management of gout: We are still failing. International Journal of Rheumatic Diseases, 27(Suppl. 2), O01. doi: 10.1111/1756-185X.15171

2023

Journal - Research Article

Stamp, L. K., Horsley, C., Te Karu, L., Dalbeth, N., & Barclay, M. (2023). Colchicine: The good, the bad, the ugly, and how to minimise the risks. Rheumatology, kead625. Advance online publication. doi: 10.1093/rheumatology/kead625

Stamp, L. K., & Te Karu, L. (2023). Reframing gout management to empower those who need it most. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.42740

Stewart, S., Gamble, G., Doyle, A. J., Son, C.-N., Aati, O., Latto, K., … Stamp, L. K., & Dalbeth, N. (2023). The statistical challenge of analysing changes in dual energy computed tomography (DECT) urate volumes in people with gout. Seminars in Arthritis & Rheumatism, 63, 152303. doi: 10.1016/j.semarthrit.2023.152303

Prendergast, E., Dalbeth, N., Bursill, D., Frampton, C., & Stamp, L. K. (2023). Uptake of the Gout and Crystal Arthritis Network (G-CAN) consensus statements for gout nomenclature. Arthritis Care & Research. Advance online publication. doi: 10.1002/acr.25250

Cao, C., Gamble, G., Horne, A., Aati, O., Doyle, A., Drake, J., Stamp, L. K., & Dalbeth, N. (2023). The Tophus Impact Questionnaire (TIQ-20): Responsiveness to change during urate-lowering therapy. Rheumatology. Advance online publication. doi: 10.1093/rheumatology/kead468

Stamp, L., Horne, A., Mihov, B., Drake, J., Haslett, J., Chapman, P. T., Frampton, C., & Dalbeth, N. (2023). Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial. Annals of the Rheumatic Diseases, 82, 1626-1634. doi: 10.1136/ard-2023-224731

Døssing, A., Conaghan, P. G., Stamp, L. K., McCarthy, G. M., Henriksen, M., Christensen, R., … Bliddal, H. (2023). Pain in hand osteoarthritis is associated with crystals in the synovial fluid: a cross-sectional study of people with hand osteoarthritis undergoing surgery. RMD Open, 9(3). doi: 10.1136/rmdopen-2023-003319

Toomata, Z., Leask, M., Krishnan, M., Cadzow, M., Dalbeth, N., Stamp, L. K., … Merriman, T., Wilcox, P., … Murphy, R. (2023). Genetic testing for misclassified monogenic diabetes in Māori and Pacific peoples in Aotearoa New Zealand with early-onset type 2 diabetes. Frontiers in Endocrinology, 14, 1174699. doi: 10.3389/fendo.2023.1174699

Tabi-Amponsah, A. D., Stewart, S., Hosie, G., Stamp, L. K., Taylor, W. J., & Dalbeth, N. (2023). Gout remission as a goal of urate-lowering therapy: A critical review. Pharmaceuticals, 16, 779. doi: 10.3390/ph16060779

Moors, J., Krishnan, M., Sumpter, N., Takei, R., Bixley, M., Cadzow, M., Major, T. J., Phipps Green, A., Topless, R., Merriman, M., Rutledge, M., Morgan, B., … Stamp, L., Taumoepeau, M., … Wilcox, P., … McCormick, S., … Merriman, T. R., & Leask, M. (2023). A Polynesian-specific missense CETP variant alters the lipid profile. Human Genetics & Genomic Advances, 4, 100204. doi: 10.1016/j.xhgg.2023.100204

Wiles, A. K., Mehta, S., Millier, M., Woolley, A. G., Li, K., Parker, K., Kazantseva, M., Wilson, M., Young, K., Bowie, S., Ray, S., Slatter, T. L., Stamp, L. K., Hessian, P. A., & Braithwaite, A. W. (2023). Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis. Arthritis Research & Therapy, 25, 62. doi: 10.1186/s13075-023-03040-8

Døssing, A., Henriksen, M., Ellegaard, K., Nielsen, S. M., Stamp, L. K., Müller, F. C., … Bliddal, H. (2023). Colchicine twice a day for hand osteoarthritis (COLOR): A double-blind, randomised, placebo-controlled trial. Lancet Rheumatology, 5(5), e254-e262. doi: 10.1016/S2665-9913(23)00065-6

Morillon, M. B., Nørup, A., Singh, J. A., Dalbeth, N., Taylor, W. J., Kennedy, M. A., … Grainger, R., … Stamp, L. K. (2023). Outcome reporting in randomized trials in Gout: A systematic scoping review from the OMERACT Gout Working Group assessing the uptake of the core outcome set. Seminars in Arthritis & Rheumatism. Advance online publication. doi: 10.1016/j.semarthrit.2023.152191

Farquhar, H. J., Beckert, N., Beckert, L., Edwards, A. L., Matteson, E. L., Frampton, C., & Stamp, L. K. (2023). Survival of adults with rheumatoid arthritis associated interstitial lung disease: A systematic review and meta-analysis. Seminars in Arthritis & Rheumatism, 60, 152187. doi: 10.1016/j.semarthrit.2023.152187

Lyne, S. A., Ruediger, C., Lester, S., Kaur, G., Stamp, L., Shanahan, E. M., & Hill, C. L. (2023). Clinical phenotype and complications of large vessel giant cell arteritis: A systematic review and meta-analysis. Joint Bone Spine. Advance online publication. doi: 10.1016/j.jbspin.2023.105558

Krishnan, M., Phipps-Green, A., Russell, E. M., Major, T. J., Cadzow, M., Stamp, L. K., Dalbeth, N., … Merriman, T. R., … Weeks, D. E. (2023). Association of rs9939609 in FTO with BMI among Polynesian peoples living in Aotearoa New Zealand and other Pacific nations. Journal of Human Genetics. Advance online publication. doi: 10.1038/s10038-023-01141-5

Chen, L., Gamble, G., Horne, A., Drake, J., Doyle, A. J., Uhlig, T., Stamp, L. K., & Dalbeth, N. (2023). Changes in tophus composition during urate-lowering therapy: A dual energy Computed Tomography study. Arthritis Care & Research, 75(9), 1949-1954. doi: 10.1002/acr.25084

Zhang, J. Z., Heinsberg, L. W., Krishnan, M., Hawley, N. L., Major, T. J., Carlson, J. C., … Stamp, L. K., … Merriman, T. R., & Weeks, D. E. (2023). Multivariate analysis of a missense variant in CREBRF reveals associations with measures of adiposity in people of Polynesian ancestries. Genetic Epidemiology, 47, 105-118. doi: 10.1002/gepi.22508

Sumpter, N. A., Takei, R., Cadzow, M., Topless, R. K. G., Phipps-Green, A. J., Murphy, R., … Major, T. J., Stamp, L. K., … Leask, M. P., … Merriman, T. R. (2023). Association of gout polygenic risk score with age at disease onset and tophaceous disease in European and Polynesian men with gout. Arthritis & Rheumatology, 75(5), 816-825. doi: 10.1002/art.42393

Carlson, J. C., Krishnan, M., Rosenthal, S. L., Russell, E. M., Zhang, J. Z., Hawley, N. L., Moors, J., … Stamp, L. K., … Merriman, T. R., … Minster, R. L. (2023). A stop-gain variant in BTNL9 is associated with atherogenic lipid profiles. Human Genetics & Genomic Advances, 4, 100155. doi: 10.1016/j.xhgg.2022.100155

Smith-Diaz, N., Stocker, S. L., Stamp, L. K., Dalbeth, N., Phipps-Green, A. J., Merriman, T. R., & Wright, D. F. B. (2023). An allopurinol adherence tool using plasma oxypurinol concentrations. British Journal of Clinical Pharmacology, 89, 1956-1964. doi: 10.1111/bcp.15516

Journal - Research Other

Stamp, L. K., & Gaffo, A. (2023). What future do biological therapies have in the treatment of gout? Expert Opinion on Biological Therapy. Advance online publication. doi: 10.1080/14712598.2023.2273936

Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., … Stamp, L. K., … Choi, H. K. (2023). The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Annals of the Rheumatic Diseases. Advance online publication. doi: 10.1136/ard-2023-224575

Stamp, L. K., Harwood, M., Dalziel, S., Love, T., Moore, D., Woock, K., Sharples, K., & Bloomfield, F. (2023). Towards a national equitable and sustainable clinical research infrastructure for Aotearoa New Zealand. New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1578), 100-112. Retrieved from https://journal.nzma.org.nz/

Hishe, H. Z., Stocker, S. L., Stamp, L. K., Dalbeth, N., Merriman, T. R., Phipps-Green, A., & Wright, D. F. B. (2023). The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics [Brief report]. Clinical & Translational Science, 16, 422-428. doi: 10.1111/cts.13460

Journal - Professional & Other Non-Research Articles

Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., … Stamp, L. K., … Choi, H. K. (2023). The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.42619

Conference Contribution - Published proceedings: Abstract

Petelytska, I., Velauthapillai, A., Tofani, L., Hachulla, E., Müller-Ladner, U., Siegert, E., … Stamp, L., … Bruni, C. (2023). Incidence and risk factors for new onset of interstitial lung disease in systemic sclerosis: A EUSTAR analysis. Arthritis & Rheumatology, 75(Suppl. 9), 1700. doi: 10.1002/art.42700

Cao, C., Gamble, G., Horne, A., Aati, O., Doyle, A., Drake, J., Stamp, L., & Dalbeth, N. (2023). The Tophus Impact Questionnaire (TIQ-20): Responsiveness to change during urate-lowering therapy. Arthritis & Rheumatology, 75(Suppl. 9), 1122. doi: 10.1002/art.42700

Tabi-Amponsah, A. D., Stewart, S., Gamble, G., Doyle, A., Son, C.-N., Latto, K., Stamp, L., Taylor, W., … Dalbeth, N. (2023). Dual Energy Computed Tomography (DECT) urate volume predicts fulfillment of gout remission after two years of intensive urate-lowering therapy. Arthritis & Rheumatology, 75(Suppl. 9), 1037. doi: 10.1002/art.42700

Prendergast, E., Dalbeth, N., Bursill, D., Frampton, C., & Stamp, L. (2023). Adherence to the Gout and Crystal Arthritis Network (G-CAN) consensus statements for gout nomenclature. Arthritis & Rheumatology, 75(Suppl. 9), 0238. doi: 10.1002/art.42700

Døssing, A., Henriksen, M., Ellegaard, K., Nielsen, S. M., Stamp, L., Müller, F. C., … Bliddal, H. (2023). Colchicine twice daily for hand osteoarthritis: Results from the double-blind, randomised, placebo-controlled COLOR trial. Annals of the Rheumatic Diseases, 82(Suppl. 1), (pp. 50). doi: 10.1136/annrheumdis-2023-eular.1205

Muir, J., Grainger, R., & Stamp, L. (2023). Understanding what works in the implementation of best-practice gout management in Aotearoa New Zealand: A realist synthesis. Internal Medicine Journal, 53(Suppl. 1), (pp. 39). doi: 10.1111/imj.16057

Muir, J., Grainger, R., & Stamp, L. (2023). Understanding and mapping gout service delivery in secondary care: A mixed methods study. Internal Medicine Journal, 53(Suppl. 1), (pp. 38-39). doi: 10.1111/imj.16057

Farquhar, H., Beckert, L., Edwards, A., Matteson, E., Yetton, R., Ganly, E., Thiessen, R., Haslett, J., Frampton, C., & Stamp, L. (2023). Rheumatoid interstitial lung disease in Canterbury, Aotearoa New Zealand. Internal Medicine Journal, 53(Suppl. 1), (pp. 29-30). doi: 10.1111/imj.16057

Wright, D., Hishe, H., Dalbeth, N., & Stamp, L. (2023). Development of a decision-support tool for allopurinol dose prediction in people with gout (The Easy-Allo tool). Internal Medicine Journal, 53(Suppl. 1), (pp. 7-8). doi: 10.1111/imj.16057

2022

Journal - Research Article

Lyne, S. A., Ruediger, C., Lester, S., Chapman, P. T., Shanahan, E. M., Hill, C. L., & Stamp, L. (2022). Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New Zealand. Frontiers in Medicine, 9, 1057917. doi: 10.3389/fmed.2022.1057917

Grayson, P. C., Ponte, C., Suppiah, R., Robson, J. C., Gribbons, K. B., Judge, A., … for the DCVAS Study Group, including Grainger, R., & Stamp, L. (2022). 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Arthritis & Rheumatology, 74(12), 1872-1880. doi: 10.1002/art.42324

Ponte, C., Grayson, P. C., Robson, J. C., Suppiah, R., Gribbons, K. B., Judge, A., … for the DCVAS Study Group, including Grainger, R., & Stamp, L. (2022). 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Arthritis & Rheumatology, 74(12), 1881-1889. doi: 10.1002/art.42325

Stamp, L. K., Grainger, R., Frampton, C., Drake, J., & Hill, C. L. (2022). Effect of omega-three supplementation on serum urate and gout flares in people with gout: A pilot randomized trial. BMC Rheumatology, 6, 31. doi: 10.1186/s41927-022-00263-1

Dalbeth, N., Mihov, B., Stewart, A., Gamble, G. D., Merriman, T. R., Mount, D., … Stamp, L. K., & Horne, A. (2022). Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation. Scientific Reports, 12(1), 12887. doi: 10.1038/s41598-022-17257-1

Coleman, G. B., Dalbeth, N., Frampton, C., Haslett, J., Drake, J., Su, I., … Stamp, L. K. (2022). Long-term follow-up of a randomised controlled trial of allopurinol dose escalation to achieve target serum urate in people with gout. Journal of Rheumatology, 49, 1372-1378. doi: 10.3899/jrheum.220270

Wang, K., Cadzow, M., Bixley, M., Leask, M. P., Merriman, M. E., Yang, Q., … Takei, R., Phipps-Green, A., Major, T. J., Topless, R., … Stamp, L. K., … Merriman, T. R. (2022). A Polynesian-specific copy number variant encompassing the MICA gene associates with gout. Human Molecular Genetics, 31(21), 3757-3768. doi: 10.1093/hmg/ddac094

Millier, M. J., Fanning, N. C., Frampton, C., Stamp, L. K., & Hessian, P. A. (2022). Plasma interleukin-23 and circulating IL-17A(⁺)IFNγ(⁺) ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis. Arthritis Research & Therapy, 24, 57. doi: 10.1186/s13075-022-02748-3

Stewart, S., Phipps-Green, A., Gamble, G. D., Stamp, L. K., Taylor, W. J., Neogi, T., Merriman, T. R., & Dalbeth, N. (2022). Is repeat serum urate testing superior to a single test to predict incident gout over time? PLoS ONE, 17(2), e0263175. doi: 10.1371/journal.pone.0263175

Wei, J., Choi, H. K., Neogi, T., Dalbeth, N., Terkeltaub, R., Stamp, L. K., … Zhang, Y. (2022). Allopurinol initiation and all-cause mortality among patients with gout and concurrent chronic kidney disease : A population-based cohort study. Annals of Internal Medicine, 175, 461-470. doi: 10.7326/m21-2347

Topless, R. K., Gaffo, A., Stamp, L. K., Robinson, P. C., Dalbeth, N., & Merriman, T. R. (2022). Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: A population-based study. Lancet Rheumatology, 4, e274-e281. doi: 10.1016/S2665-9913(21)00401-X

Dalbeth, N., Doyle, A. J., Billington, K., Gamble, G. D., Tan, P., Latto, K., … Stamp, L. K., & Horne, A. (2022). Intensive serum urate lowering with oral urate-lowering therapy for erosive gout: A randomized double-blind controlled trial. Arthritis & Rheumatology, 74(6), 1059-1069. doi: 10.1002/art.42055

Stamp, L. K., Frampton, C., Morillon, M. B., Taylor, W. J., Dalbeth, N., Singh, J. A., … Christensen, R. (2022). Association between serum urate and flares in people with gout and evidence for surrogate status: A secondary analysis of two randomised controlled trials. Lancet Rheumatology, 4(1), e53-e60. doi: 10.1016/S2665-9913(21)00319-2

Tedeschi, S. K., Pascart, T., Latourte, A., Godsave, C., Kundakci, B., Naden, R. P., Taylor, W. J., … Stamp, L. K., … Abhishek, A. (2022). Identifying potential classification criteria for calcium pyrophosphate deposition disease (CPPD): Item generation and item reduction. Arthritis Care & Research, 74(10), 1649-1658. doi: 10.1002/acr.24619

Journal - Research Other

Stamp, L. K., & Dalbeth, N. (2022). Critical appraisal of serum urate targets in the management of gout. Nature Reviews Rheumatology, 18, 603-609. doi: 10.1038/s41584-022-00816-1

Farquhar, H., Beckert, L., Edwards, A., Matteson, E. L., Thiessen, R., Ganly, E., & Stamp, L. K. (2022). Rheumatoid interstitial lung disease in Canterbury New Zealand: Prevalence, risk factors and long-term outcomes: Protocol for a population-based retrospective study. BMJ Open, 12(4), e050934. doi: 10.1136/bmjopen-2021-050934

Journal - Professional & Other Non-Research Articles

Ponte, C., Grayson, P. C., Robson, J. C., Suppiah, R., Gribbons, K. B., Judge, A., … for the DCVAS Study Group, including Grainger, R., & Stamp, L. (2022). 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Annals of the Rheumatic Diseases, 81, 1647-1653. doi: 10.1136/ard-2022-223482

Grayson, P. C., Ponte, C., Suppiah, R., Robson, J. C., Gribbons, K. B., Judge, A., … for the DCVAS Study Group, including Grainger, R., & Stamp, L. (2022). 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Annals of the Rheumatic Diseases, 81, 1654-1660. doi: 10.1136/ard-2022-223482

Conference Contribution - Published proceedings: Abstract

Chen, L., Gamble, G., Horne, A., Drake, J., Doyle, A., Uhlig, T., Stamp, L., & Dalbeth, N. (2022). Changes in tophus composition during urate-lowering therapy: A dual energy CT study. Arthritis & Rheumatology, 74(Suppl. 9), 2203. doi: 10.1002/art.42355

Merriman, T., Matsuo, H., Takei, R., Leask, M., Topless, R., Shirai, Y., … Cadzow, M., … Stamp, L., … Robinson, P., … Sumpter, N., Merriman, M., Phipps-Green, A., Wei, W., McCormick, S., … Major, T. (2022). A genome-wide association analysis of 2,622,830 individuals reveals new pathogenic pathways in gout. Arthritis & Rheumatology, 74(Suppl. 9), 1678. doi: 10.1002/art.42355

Chuah, M. H., Topless, R., Gamble, G., Sumpter, N., Stamp, L., Merriman, T., & Dalbeth, N. (2022). Interaction of LOC100507053, ADH1B, and ADH1C with alcohol consumption for elevated serum urate levels and gout in people of European ethnicity. Arthritis & Rheumatology, 74(Suppl. 9), 1132. doi: 10.1002/art.42355

Archer, A., Topless, R., Gaffo, A., Dalbeth, N., Stamp, L., Robinson, P., & Merriman, T. (2022). Inflammatory rheumatic disease and the risk of death related to Coronavirus Disease-19 (COVID-19): An analysis of the UK Biobank with stratification by sex. Arthritis & Rheumatology, 74(Suppl. 9), 0721. doi: 10.1002/art.42355

Gray, D., Ewers, E., Phipps-Green, A., Campbell, A., Porteous, D. E., Morris, S., … Stamp, L. K., Merriman, T. R., Thunders, M. C., & Major, T. J. (2022). Brothers discordant for gout have differing DNA methylation patterns in inflammatory genes. In L. Wilson, H. Harcombe, P. Jayakaran, L. Burga, J. Antony, K. Morgaine, M. Garelja, A. Middleton, M. Anwar & T. Milne (Eds.), Proceedings of the 264th Otago Medical School Research Society (OMSRS) Meeting: Masters/Honours Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839

Dickerson, R. R., Shaukat, A., Bixley, M., Cadzow, M., Major, T., Phipps-Green, A., Topless, R., … Stamp, L., … Gosling, A., & Merriman, T. (2022). Mitochondrial disfunction: Key to rates of gout in Polynesia? American Journal of Biological Anthropology, 177(S23), (pp. 47). doi: 10.1002/ajpa.24514

Chan, S. J., Stamp, L., Treharne, G., & Marra, C. (2022). Preference of rheumatoid arthritis patients for tapering biologics: A discrete choice experiment. Value in Health, 25(1, Suppl.), (pp. S4). doi: 10.1016/j.jval.2021.11.016

Conference Contribution - Verbal presentation and other Conference outputs

Gray, D., Ewers, E., Phipps-Green, A., Campbell, A., Porteous, D. E., Morris, S., … Dalbeth, N., Stamp, L. K., Merriman, T. R., Thunders, M. C., & Major, T. J. (2022, September). Brothers discordant for gout have differing DNA methylation patterns in inflammatory genes. Verbal presentation at the Postgraduate & Early Career Researchers Committee (PERC) & Division of Health Sciences Early & Mid-Career Researcher (EMCR) Joint Research Symposium, Dunedin, New Zealand.

Commissioned Report for External Body

Enhancing Aotearoa New Zealand Clinical Trials Project Team, including, Sharples, K., Stamp, L., Darlow, B., Baxter, D., Nixon, G., & Stokes, T. (2022). Enhancing Aotearoa New Zealand clinical trials. Commissioned by Ministry of Health and Health Research Council of New Zealand. Auckland, New Zealand: University of Auckland. 40p. Retrieved from https://www.auckland.ac.nz/en/liggins/our-research/reports-and-guidelines.html

2021

Journal - Research Article

Son, C.-N., Cai, K., Stewart, S., Ferrier, J., Billington, K., Tsai, Y.-J. J., … Stamp, L. K., … Dalbeth, N. (2021). Development of a radiographic scoring system for new bone formation in gout. Arthritis Research & Therapy, 23, 296. doi: 10.1186/s13075-021-02683-9

Morillon, M. B., Christensen, R., Singh, J. A., Dalbeth, N., Saag, K., Taylor, W. J., … Kennedy, M. A., … Grainger, R., … Stamp, L. K., for the OMERACT Gout Working Group. (2021). Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT Working Group. Seminars in Arthritis & Rheumatism, 51, 1378-1385. doi: 10.1016/j.semarthrit.2021.11.004

Emde, A.-K., Phipps-Green, A., Cadzow, M., Gallagher, C. S., Major, T. J., Merriman, M. E., Topless, R. K., Takei, R., Dalbeth, N., … Stamp, L. K., … Wilcox, P. L., … Merriman, T. R., & Castel, S. E. (2021). Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations. BMC Genomics, 22, 666. doi: 10.1186/s12864-021-07949-9

Stamp, L. K., & Farquhar, H. (2021). Treatment advances in gout. Best Practice & Research: Clinical Rheumatology, 35, 101719. doi: 10.1016/j.berh.2021.101719

Robinson, P. C., Frampton, C., Phipps-Green, A., Neogi, T., Stamp, L., Taylor, W., Merriman, T. R., & Dalbeth, N. (2021). Longitudinal development of incident gout from low-normal baseline serum urate concentrations: Individual participant data analysis. BMC Rheumatology, 5(1), 33. doi: 10.1186/s41927-021-00204-4

Badii, M., Gaal, O. I., Cleophas, M. C., Klück, V., Davar, R., Habibi, E., … Stamp, L. K., … Phipps-Green, A. J., … Merriman, T. R., … Joosten, L. A. B. (2021). Urate-induced epigenetic modifications in myeloid cells. Arthritis Research & Therapy, 23, 202. doi: 10.1186/s13075-021-02580-1

Stamp, L. K., Farquhar, H., Pisaniello, H. L., Vargas-Santos, A. B., Fisher, M., Mount, D. B., … Gaffo, A. L. (2021). Management of gout in chronic kidney disease: A G-CAN consensus statement on the research priorities. Nature Reviews Rheumatology, 17, 633-641. doi: 10.1038/s41584-021-00657-4

Ji, A., Shaukat, A., Takei, R., Bixley, M., Cadzow, M., Topless, R. K., Major, T. J., Phipps-Green, A., Merriman, M. E., … Stamp, L. K., Dalbeth, N., … Merriman, T. R. (2021). Aotearoa New Zealand Māori and Pacific population-specific gout risk variants: CLNK is a separate risk gene at the SLC2A9 locus. Journal of Rheumatology, 48, 1736-1744. doi: 10.3899/jrheum.201684

Te Karu, L., Dalbeth, N., & Stamp, L. K. (2021). Inequities in people with gout: A focus on Māori (indigenous people) of Aotearoa New Zealand. Therapeutic Advances in Musculoskeletal Disease, 13. doi: 10.1177/1759720x211028007

Cai, K., Fuller, A., Zhang, Y., Hensey, O., Grossberg, D., Christensen, R., … Taylor, W. J., … Stamp, L. K., … Dalbeth, N. (2021). Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. Seminars in Arthritis & Rheumatism, 51, 946-950. doi: 10.1016/j.semarthrit.2021.04.019

Topless, R. K., Phipps-Green, A., Leask, M., Dalbeth, N., Stamp, L. K., Robinson, P. C., & Merriman, T. R. (2021). Gout, rheumatoid arthritis, and the risk of death related to coronavirus disease 2019: An analysis of the UK Biobank. ACR Open Rheumatology, 3(5), 333-340. doi: 10.1002/acr2.11252

Topless, R. K. G., Major, T. J., Florez, J. C., Hirschhorn, J. N., Cadzow, M., Dalbeth, N., Stamp, L. K., Wilcox, P. L., … Merriman, T. R. (2021). The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: Diet has a weak causal effect. Arthritis Research & Therapy, 23(1), 75. doi: 10.1186/s13075-021-02444-8

Døssing, A., Müller, F. C., Becce, F., Stamp, L., Bliddal, H., & Boesen, M. (2021). Dual-energy computed tomography for detection and characterization of monosodium urate, calcium pyrophosphate, and hydroxyapatite: A phantom study on diagnostic performance. Investigative Radiology, 56(7), 417-424. doi: 10.1097/rli.0000000000000756

Dalbeth, N., Horne, A., Mihov, B., Stewart, A., Gamble, G. D., Merriman, T. R., Stamp, L. K., & Reid, I. R. (2021). Elevated urate does not alter bone turnover markers: Randomized controlled trial of inosine supplementation in post-menopausal women. Arthritis & Rheumatology, 73(9), 1758-1764. doi: 10.1002/art.41691

Hudson, B., Williman, J. A., Stamp, L. K., Alchin, J. S., Hooper, G. J., Mangin, D., Lennox Thompson, B. F., & Toop, L. (2021). Nortriptyline for pain in knee osteoarthritis in general practice: A double blind randomised controlled trial. British Journal of General Practice, 71(708), e538-e546. doi: 10.3399/bjgp.2020.0797

Stamp, L. K., Cameron, V. A., Woodfield, T. B. F., Walker, L., Currie, M., Templeton, E., Pilbrow, A. P., Tabakakis, K., Phillips, E., & Lim, K. S. (2021). Impact of COVID-19 on health research in New Zealand: A case study of a research-intensive campus. Journal of the Royal Society of New Zealand, 51(Suppl. 1), S75-S85. doi: 10.1080/03036758.2020.1867202

Narang, R. K., Gamble, G. G., Topless, R., Cadzow, M., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2021). Assessing the relationship between serum urate and urolithiasis using Mendelian randomization: An analysis of the UK Biobank. American Journal of Kidney Diseases, 78(2), 210-218. doi: 10.1053/j.ajkd.2020.11.018

Jagpal, A., Rahn, E. J., Mudano, A. S., Dalbeth, N., Taylor, W., Saag, K. G., … Stamp, L., … Gaffo, A. (2021). Which factors predict discordance between a patient and physician on a gout flare? Rheumatology, 60, 773-779. doi: 10.1093/rheumatology/keaa413

Takei, R., Cadzow, M., Markie, D., Bixley, M., Phipps-Green, A., Major, T. J., … Stamp, L. K., … Merriman, T. R., & Wei, W.-H. (2021). Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects. Journal of Human Genetics, 66, 161-169. doi: 10.1038/s10038-020-0821-z

Taylor, W., Dalbeth, N., Saag, K. G., Singh, J. A., Rahn, E. J., Mudano, A. S., … Stamp, L. K., … Gaffo, A. L. (2021). Flare rate thresholds for patient assessment of disease activity states in gout. Journal of Rheumatology, 48, 293-298. doi: 10.3899/jrheum.191242

Journal - Research Other

Pisaniello, H. L., Fisher, M. C., Farquhar, H., Vargas-Santos, A. B., Hill, C. L., Stamp, L. K., & Gaffo, A. L. (2021). Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review. Arthritis Research & Therapy, 23, 130. doi: 10.1186/s13075-021-02416-y

Bernabei, I., Sayous, Y., Raja, A. Y., Amma, M. R., Viry, A., Steinmetz, S., … Stamp, L. K., … Becce, F. (2021). Multi-energy photon-counting computed tomography versus other clinical imaging techniques for the identification of articular calcium crystal deposition. Rheumatology, 60, 2483-2485. doi: 10.1093/rheumatology/keab125

Farquhar, H., Vargas-Santos, A. B., Pisaniello, H. L., Fisher, M., Hill, C., Gaffo, A. L., & Stamp, L. K. (2021). Efficacy and safety of urate-lowering therapy in people with kidney impairment: A GCAN-initiated literature review. Rheumatology Advances in Practice, 5(1), rkaa073. doi: 10.1093/rap/rkaa073

Choi, H. K., Neogi, T., Stamp, L. K., Terkeltaub, R., & Dalbeth, N. (2021). Reassessing the cardiovascular safety of febuxostat: Implications of the FAST study. Arthritis & Rheumatology, 73(5), 721-724. doi: 10.1002/art.41638

Chan, S. J., Yeo, H. Y., Stamp, L. K., Treharne, G. J., & Marra, C. A. (2021). What are the preferences of patients with rheumatoid arthritis for treatment modification? A scoping review. Patient, 14, 505-532. doi: 10.1007/s40271-020-00488-7

Stamp, L. K., Taylor, W., & Gaffo, A. (2021). Variability in urate-lowering therapy prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) physician survey. Journal of Rheumatology, 48(1), 152-153. doi: 10.3899/jrheum.200347

Conference Contribution - Published proceedings: Abstract

Hishe, H. Z., Stocker, S. L., Stamp, L. K., & Wright, D. F. B. (2021). Population pharmacokinetics and exposure-response analyses for allopurinol in patients with gout. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: 20/20 Hindsight: Creating a Sustainable Future for Pharmacology and Toxicology. 323. Retrieved from https://www.ascept.org/

Chan, S. J., Stamp, L. K., Treharne, G. J., & Marra, C. A. (2021). The preferences of people with rheumatoid arthritis for tapering biologic therapies. New Zealand Medical Journal, 134(1547), (pp. 136-137). Retrieved from https://www.nzma.org.nz/journal

Ewers, E., Phipps-Green, A., Dalbeth, N., Stamp, L. K., Merriman, T. R., Thunders, M. C., & Major, T. J. (2021). Brothers discordant for gout have differing DNA methylation levels in inflammatory genes. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go

Dalbeth, N., Doyle, A., Billington, K., Gamble, G., Tan, P., Latto, K., … Stamp, L., & Horne, A. (2021). A randomized double-blind controlled trial of intensive serum urate lowering with oral urate-lowering threapy for erosive gout. Arthritis & Rheumatology, 73(Suppl. 9), (pp. 3962-3963). doi: 10.1002/art.41966

Dalbeth, N., Mihov, B., Stewart, A., Gamble, G., Merriman, T., Mount, D., Stamp, L., … Horne, A. (2021). Effect of elevated serum urate on kidney function: Analysis of a randomized controlled trial of inosine supplementation. Arthritis & Rheumatology, 73(Suppl. 9), (pp. 3282-3284). doi: 10.1002/art.41966

Stewart, S., Phipps-Green, A., Gamble, G., Stamp, L., Taylor, W., Neogi, T., Merriman, T., & Dalbeth, N. (2021). Is repeat serum urate testing superior to a single test to predict incident gout over time? Arthritis & Rheumatology, 73(Suppl. 9), (pp. 3044-3045). doi: 10.1002/art.41966

Schlesinger, N., Sumpter, N. A., Dalbeth, N., Stamp, L., & Merriman, T. (2021). Is there a difference in self-reported flare frequency between men and women? Arthritis & Rheumatology, 73(Suppl. 9), (pp. 1377-1379). doi: 10.1002/art.41966

Stamp, L., Frampton, C., Morillon, M., Taylor, W., Dalbeth, N., Singh, J., … Christensen, R. (2021). Serum urate reduction is causally associated with flare outcomes in people with gout: Evidence for surrogate status from a pooled analysis of 2 randomized trials. Arthritis & Rheumatology, 73(Suppl. 9), (pp. 1350-1351). doi: 10.1002/art.41966

Stamp, L., Grainger, R., Frampton, C., Drake, J., & Hill, C. (2021). Effect of omega-three supplementation on serum urate and gout flares in people with gout: A pilot randomized trial. Arthritis & Rheumatology, 73(Suppl. 9), (pp. 1348-1349). doi: 10.1002/art.41966

Tedeschi, S., Pascart, T., Latourte, A., Godsave, C., Kundakci, B., Naden, R., Taylor, W., … Stamp, L., … Abhishek, A. (2021). Identifying potential classification criteria for calcium pyrophosphate deposition disease (CPPD): Results from the initial phases. Annals of the Rheumatic Diseases, 80(Suppl. 1), POS1124. doi: 10.1136/annrheumdis-2021-eular.469

Conference Contribution - Poster Presentation (not in published proceedings)

Lyne, S., Ruediger, C., Ninan, J., Lester, S., Dyer, K., Dodd, T., Stamp, L., … Hill, C. (2021, August). How HLA-DRB1*04 status affects clinical phenotype of patients with giant cell arteritis in South Australia. Poster session presented at the New Zealand Rheumatology Association (NZRA) Annual Scientific Meeting, [Online].

Conference Contribution - Verbal presentation and other Conference outputs

Dalbeth, N., Doyle, A., Billington, K., Gamble, G., Tan, P., Latto, K., … Stamp, L., & Horne, A. (2021, August). A randomised double-blind controlled trial of intensive serum urate lowering with oral urate-lowering therapy for erosive gout. Verbal presentation at the New Zealand Rheumatology Association (NZRA) Annual Scientific Meeting, [Online].

Stamp, L., Frampton, C., Morillon, M., Taylor, W., Dalbeth, N., Singh, J., … Christensen, R. (2021, August). Serum urate reduction is causally associated with flare outcomes in people with gout: Evidence for surrogate status from a pooled analysis of 2 randomized trials. Verbal presentation at the New Zealand Rheumatology Association (NZRA) Annual Scientific Meeting, [Online].

Farquhar, H., Haslett, J., Edwards, A., Matteson, E., Beckert, L., & Stamp, L. (2021, August). Incidence and prevalence of rheumatoid arthritis and rheumatoid interstitial lung disease in Canterbury, New Zealand: A population based retrospective study. Verbal presentation at the New Zealand Rheumatology Association (NZRA) Annual Scientific Meeting, [Online].

Coleman, G., Dalbeth, N., Frampton, C., Haslett, J., Drake, J., Su, I., … Stamp, L. (2021, August). Long-term follow-up of a randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout. Verbal presentation at the New Zealand Rheumatology Association (NZRA) Annual Scientific Meeting, [Online].

2020

Journal - Research Article

Grainger, R., Townsley, H. R., Stebbings, S., Harrison, A. A., Taylor, W. J., & Stamp, L. K. (2020). Codevelopment of patient self-examination methods and joint count reporting for rheumatoid arthritis [Brief report]. ACR Open Rheumatology, 2(12), 705-709. doi: 10.1002/acr2.11197

Millier, M. J., Lazaro, K., Stamp, L. K., & Hessian, P. A. (2020). The contribution from interleukin-27 towards rheumatoid inflammation: Insights from gene expression. Genes & Immunity, 21, 249-259. doi: 10.1038/s41435-020-0102-z

Hoque, K. M., Dixon, E. E., Lewis, R. M., Allan, J., Gamble, G. D., Phipps-Green, A. J., … Stamp, L. K., Merriman, T. R., … Woodward, O. M. (2020). The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Nature Communications, 11, 2767. doi: 10.1038/s41467-020-16525-w

Klück, V., van Deuren, R. C., Cavalli, G., Shaukat, A., Arts, P., Cleophas, M. C., … Stamp, L. K., … Merriman, T. R., … Joosten, L. A. B. (2020). Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout. Annals of the Rheumatic Diseases, 79(4), 536-544. doi: 10.1136/annrheumdis-2019-216233

Wrigley, R., Phipps-Green, A. J., Topless, R. K., Major, T. J., Cadzow, M., Riches, P., … Stamp, L. K., … Merriman, T. R. (2020). Pleiotropic effect of the ABCG2 gene in gout: Involvement in serum urate levels and progression from hyperuricemia to gout. Arthritis Research & Therapy, 22, 45. doi: 10.1186/s13075-020-2136-z

Zaidi, F., Narang, R. K., Phipps-Green, A., Gamble, G. G., Tausche, A.-K., So, A., … Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2020). Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus. Rheumatology, 59, 2544-2549. doi: 10.1093/rheumatology/kez685

Narang, R. K., Gamble, G., Phipps-Green, A. J., Topless, R., Cadzow, M., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2020). Do serum urate-associated genetic variants influence gout risk in people on diuretics? Analysis of the UK Biobank. Journal of Rheumatology, 47, 1704-1711. doi: 10.3899/jrheum.191005

Tai, V., Narang, R. K., Gamble, G., Cadzow, M., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2020). Do serum urate-associated genetic variants differentially contribute to gout risk according to body mass index? Analysis of the UK Biobank. Arthritis & Rheumatology, 72(7), 1184-1191. doi: 10.1002/art.41219

Stamp, L. K., Chapman, P., Frampton, C., Duffull, S. B., Drake, J., Zhang, Y., & Neogi, T. (2020). Lack of effect of tart cherry concentrate dose on serum urate in people with gout. Rheumatology, 59, 2374-2380. doi: 10.1093/rheumatology/kez606

Chan, S. J., Stamp, L. K., Liebergreen, N., Ndukwe, H., Marra, C., & Treharne, G. J. (2020). Tapering biologic therapy for rheumatoid arthritis: A qualitative study of patient perspectives. Patient, 13, 225-234. doi: 10.1007/s40271-019-00403-9

Metcalfe, L. K., Krishnan, M., Turner, N., Yaghootkar, H., Merry, T. L., Dewes, O., … Stamp, L. K., Merriman, T. R., … Murphy, R. (2020). The Māori and Pacific specific CREBRF variant and adult height. International Journal of Obesity, 44, 748-752. doi: 10.1038/s41366-019-0437-6

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Merriman, T. R., Wright, D. F. B., … Dalbeth, N. (2020). Relationships between allopurinol dose, oxypurinol concentration and urate-lowering response: In search of a minimum effective oxypurinol concentration. Clinical & Translational Science, 13, 110-115. doi: 10.1111/cts.12686

Journal - Research Other

Dalbeth, N., Stamp, L. K., & Taylor, W. J. (2020). What is remission in gout and how should we measure it? Rheumatology. doi: 10.1093/rheumatology/keaa853

Ryan, J., Tieu, J., Bose, B., Francis, R., Gingold, M., Goh, L., … Stamp, L. K., … Kitching, R. (2020). Formation of the Australia and New Zealand Vasculitis Society to improve the care of patients with vasculitis in Australian and New Zealand. Internal Medicine Journal, 50(7), 781-783. doi: 10.1111/imj.14898

Stamp, L. K., & Chapman, P. T. (2020). Allopurinol hypersensitivity: Pathogenesis and prevention. Best Practice & Research: Clinical Rheumatology, 34, 101501. doi: 10.1016/j.berh.2020.101501

Becce, F., Viry, A., Stamp, L. K., Pascart, T., Budzik, J.-F., MARS Collaboration, & Raja, A. (2020). Du nouveau dans l’imagerie des maladies à dépôts de cristaux de calcium. Revue du Rhumatisme, 87, 235-238. doi: 10.1016/j.rhum.2020.01.029

Conference Contribution - Published proceedings: Abstract

Topless, R., Major, T., Florez, J., Hirschhorn, J., Cadzow, M., Dalbeth, N., Stamp, L., Wilcox, P., … Merriman, T. (2020). The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: Diet has a weak causal effect. Arthritis & Rheumatology, 72(Suppl. 10), 0951. [Abstract]

Leask, M., Dalbeth, N., Stamp, L., Merriman, T., Phipps-Green, A., Topless, R., Boocock, J., … Leaupepe, K., & Stahl, E. (2020). Polynesian-specific gout-associated frameshift variant in PRPSAP1. Arthritis & Rheumatology, 72(Suppl. 10), 0659. [Abstract]

Zobbe, K., Christensen, R., Nielsen, S. M., Stamp, L., Henriksen, M., Overgaard, A., … Kristensen, L. E. (2020). Weight loss as treatment for gout in patients with concomitant obesity: A proof-of-concept randomized controlled trial. Arthritis & Rheumatology, 72(Suppl. 10), 0655. [Abstract]

Major, T., Topless, R., Sanchez-Lopez, E., Harré Hindmarsh, J., Stamp, L., Dalbeth, N., … Merriman, T. (2020). Nutrient content of gout flare trigger foods. Arthritis & Rheumatology, 72(Suppl. 10), 0653. [Abstract]

Dalbeth, N., Horne, A., Mihov, B., Merriman, T., Gamble, G., Stamp, L., & Reid, I. (2020). Does urate directly influence bone turnover? Randomized controlled trial of inosine supplementation. Arthritis & Rheumatology, 72(Suppl. 10), 0110. [Abstract]

Chan, S. J., Stamp, L. K., Liebergreen, N., Ndukwe, H., Marra, C. A., & Treharne, G. (2020). Rheumatoid arthritis patients' perspectives on tapering biologic therapy: A qualitative study. New Zealand Medical Journal, 133(1527), (pp. 128-129). Retrieved from https://www.nzma.org.nz/journal

Moors, J., Leask, M., Dalbeth, N., Stamp, L., Hindmarsh, J. H., & Merriman, T. (2020). Novel CETP variant associates with increased HDL and low LDL in Polynesian populations. In A. Finigan, P. Vakaoti, R. Richards, M. Schaaf, M. Colombo, M. Taumoepeau & L. Moata'ane (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices XVII. (pp. 33). Dunedin, New Zealand: Pacific Islands Centre, University of Otago. Retrieved from https://www.otago.ac.nz/pacific

Zobbe, K., Nielsen, S. M., Christensen, R., Overgaard, A., Gudbergsen, H., Henriksen, M., … Stamp, L., … Kristensen, L. E. (2020). Effect of weight loss and liraglutide on serum urate levels among obese knee osteoarthritis patients: Secondary analysis of a randomised controlled trial. Annals of the Rheumatic Diseases, 79(Suppl. 1), (pp. 107-108). doi: 10.1136/annrheumdis-2020-eular.3088

Working Paper; Discussion Paper; Technical Report

Fanning, N. C., Topless, R. K., Phipps-Green, A., Pearson, J. F., Cadzow, M., Major, T. J., … Merriman, T. R., & Stamp, L. K. (2020). Population-specific interaction of the TRIM46/MUC1 locus with cigarette smoking may influence the risk of gout. Research Square. doi: 10.21203/rs.3.rs-108669/v1

Wrigley, R., Phipps-Green, A. J., Topless, R. K., Major, T. J., Cadzow, M., Riches, P., … Stamp, L. K., … Merriman, T. R. (2020). Pleiotropic effect of ABCG2 in gout: Involvement in serum urate levels and progression from hyperuricemia to gout. bioRxiv. doi: 10.1101/2020.01.06.894899

2019

Journal - Research Article

Stamp, L. K., O'Donnell, J. L., Frampton, C., Drake, J., Zhang, M., Barclay, M., & Chapman, P. (2019). A pilot randomized controlled double-blind trial of high- versus low-dose weekly folic acid in people with rheumatoid arthritis receiving methotrexate. Journal of Clinical Rheumatology, 25(7), 284-287. doi: 10.1097/RHU.0000000000000848

Becker, M., Graf, N., Sauter, R., Allanore, Y., Curram, J., Denton, C. P., … EUSTAR Collaborators, including Stebbings, S., Highton, J., Stamp, L., Chapman, P., & O'Donnell, J. (2019). Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis. Annals of the Rheumatic Diseases, 78(9), 1242-1248. doi: 10.1136/annrheumdis-2019-215145

Dalbeth, N., Choi, H. K., Joosten, L. A. B., Khanna, P. P., Matsuo, H., Perez-Ruiz, F., & Stamp, L. K. (2019). Gout. Nature Reviews Disease Primers, 5, 69. doi: 10.1038/s41572-019-0115-y

Stamp, L. K., Chapman, P., Hudson, B., Frampton, C., Hamilton, G., & Judd, A. (2019). The challenges of managing gout in primary care: Results of a best-practice audit. Australian Journal of General Practice, 48(9), 631-637. doi: 10.31128/AJGP-04-19-4909

Sobanski, V., Giovannelli, J., Allanore, Y., Riemekasten, G., Airò, P., Vettori, S., … and the EUSTAR Collaborators, including Stebbings, S., Highton, J., Stamp, L., Chapman, P., & O'Donnell, J. (2019). Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis. Arthritis & Rheumatology, 71(9), 1553-1570. doi: 10.1002/art.40906

Wu, W., Jordan, S., Graf, N., de Oliveira Pena, J., Curram, J., Allanore, Y., … EUSTAR Collaborators, including Stebbings, S., Highton, J., Stamp, L., Chapman, P., & O'Donnell, J. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5), 648-656. doi: 10.1136/annrheumdis-2018-213455

Dalbeth, N., Billington, K., Doyle, A., Frampton, C., Tan, P., Aati, O., … Stamp, L. K. (2019). Effects of allopurinol dose escalation on bone erosion and urate volume in gout: A dual-energy computed tomography imaging study within a randomized, controlled trial. Arthritis & Rheumatology, 71(10), 1739-1746. doi: 10.1002/art.40929

Yeo, E., Palmer, S. C., Chapman, P. T., Frampton, C., & Stamp, L. K. (2019). Serum urate levels and therapy in adults treated with long-term dialysis: A retrospective cross-sectional study. Internal Medicine Journal, 49(7), 838-842. doi: 10.1111/imj.14163

Barclay, M. L., Karim, S., Helms, E. T. J., Keating, P. E., Hock, B., Stamp, L. K., & Schultz, M. (2019). Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays. Internal Medicine Journal, 49, 513-518. doi: 10.1111/imj.14064

Journal - Research Other

Dalbeth, N., Reid, S., Stamp, L. K., & Arroll, B. (2019). Making the right thing the easy thing to do: Strategies to improve outcomes in gout. Lancet Rheumatology, 1(2), e122-e131. doi: 10.1016/S2665-9913(19)30004-9

Stamp, L. K., Frampton, C., Drake, J., Doughty, R. N., Troughton, R. W., & Richards, A. M. (2019). Associations of gout and baseline serum urate with cardiovascular outcomes: Analysis of the Coronary Disease Cohort Study. Arthritis & Rheumatology, 71(10), 1733-1738. doi: 10.1002/art.41007

Stamp, L. K., Chan, S. J., Marra, C., Helme, C., & Treharne, G. J. (2019). Tapering biologic therapy for people with rheumatoid arthritis in remission: A review of patient perspectives and associated clinical evidence. Musculoskeletal Care, 17(3), 161-169. doi: 10.1002/msc.1404

Becce, F., Viry, A., Stamp, L. K., Pascart, T., Budzik, J.-F., MARS Collaboration, & Raja, A. (2019). Winds of change in imaging of calcium crystal deposition diseases. Joint Bone Spine, 86(6), 665-668. doi: 10.1016/j.jbspin.2019.04.005

Stamp, L. K., Anderson, N. G., Becce, F., Rajeswari, M., Polson, M., Guyen, O., … Choi, C., … Raja, A. Y. (2019). Clinical utility of multi-energy spectral photon-counting computed tomography in crystal arthritis [Brief report]. Arthritis & Rheumatology, 71(7), 1158-1162. doi: 10.1002/art.40848

Stamp, L. K., Topless, R., Miner, J. N., Dalbeth, N., & Merriman, T. (2019). No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat. Rheumatology, 58, 547-548. doi: 10.1093/rheumatology/key423

Stamp, L. K., & Dalbeth, N. (2019). Prevention and treatment of gout. Nature Reviews Rheumatology, 15, 68-70. doi: 10.1038/s41584-018-0149-7

Stamp, L. K., Wright, D. F. B., & Dalbeth, N. (2019). Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate! [Letter to the editor]. British Journal of Clinical Pharmacology, 85, 1378-1379. doi: 10.1111/bcp.13798

Journal - Professional & Other Non-Research Articles

Choi, H., Neogi, T., Stamp, L., Dalbeth, N., & Terkeltaub, R. (2019). Reply. Arthritis & Rheumatology, 71(11), 1967-1968. doi: 10.1002/art.41065

Bursill, D., Taylor, W. J., Terkeltaub, R., Abhishek, A., So, A. K., Vargas-Santos, A. B., … Stamp, L., … Chapman, P. T., … Grainger, R., … Merriman, T., … Dalbeth, N. (2019). Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Annals of the Rheumatic Diseases, 78(11), 1592-1600. doi: 10.1136/annrheumdis-2019-215933

Bursill, D., Taylor, W. J., Terkeltaub, R., Kuwabara, M., Merriman, T. R., Grainger, R., … Chapman, P. T., … Stamp, L. K., … Dalbeth, N. (2019). Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care & Research, 71(3), 427-434. doi: 10.1002/acr.23607

Conference Contribution - Published proceedings: Abstract

Stamp, L. K. (2019). Allopurinol at the coal face: Can we really get to target with an old drug? Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 54). Retrieved from https://www.asceptasm.com

Sumpter, N., Merriman, T., Reynolds, R., Abhishek, A., Andres, M., Dalbeth, N., … Stamp, L., … Uhlig, T. (2019). Association of a gout polygenic risk score with disease severity phenotypes amongst caucasian gout patients in three independent cohorts. Arthritis & Rheumatology, 71(Suppl. 10), 2839. doi: 10.1002/art.41108

Tai, V., Narang, R., Gamble, G., Stamp, L., Merriman, T., & Dalbeth, N. (2019). Do serum urate-associated genetic variants deferentially contribute to gout risk according to body mass index? Analysis of the UK Biobank. Arthritis & Rheumatology, 71(Suppl. 10), 2836. doi: 10.1002/art.41108

Fanning, N., Topless, R., Frampton, C., Cadzow, M., Wallace, M., Dalbeth, N., Merriman, T., & Stamp, L. (2019). A burden of missense genetic variants in urate secretory genes is associated with inadequate response to allopurinol in people with gout. Arthritis & Rheumatology, 71(Suppl. 10), 2835. doi: 10.1002/art.41108

Hudson, B., Toop, L., Williman, J., Hooper, G., Mangin, D., Alchin, J., Thompson, B., & Stamp, L. (2019). Nortriptyline in knee arthritis (nortika): A randomised controlled double blind trial of nortriptyline for pain in knee osteoarthritis. Arthritis & Rheumatology, 71(Suppl. 10), 2758. doi: 10.1002/art.41108

Stamp, L., Keating, P., Frampton, C., Barclay, M., Fanning, N., Millier, M., Hessian, P., & O'Donnell, J. (2019). Relationship between adalimumab concentrations, plasma cytokines, anti-drug antibodies and disease activity in rheumatoid arthritis. Arthritis & Rheumatology, 71(Suppl. 10), 1440. doi: 10.1002/art.41108

Grainger, R., Stebbings, S., Taylor, W., Harrison, A., Capistrano, C., Fanning, N., & Stamp, L. (2019). Self-joint counts by people with rheumatoid arthritis: Does a video increase accuracy and does it matter? Arthritis & Rheumatology, 71(Suppl. 10), 1366. doi: 10.1002/art.41108

Narang, R., Gamble, G., Phipps-Green, A., Topless, R., Cadzow, M., Stamp, L., Merriman, T., & Dalbeth, N. (2019). Do serum urate-associated genetic variants influence gout risk in people on diuretics? Analysis of the UK biobank. Arthritis & Rheumatology, 71(Suppl. 10), 1230. doi: 10.1002/art.41108

Stamp, L., Chapman, P., Barclay, M., Horne, A., Frampton, C., Merriman, T., Wright, D., … Dalbeth, N. (2019). Relationships between allopurinol dose, oxypurinol levels and serum urate: In search of an oxypurinol therapeutic concentration. Arthritis & Rheumatology, 71(Suppl. 10), 1222. doi: 10.1002/art.41108

Stamp, L., Zhang, Y., Frampton, C., Drake, J., Chapman, P., Duffull, S., & Neogi, T. (2019). Lack of effect of tart cherry concentrate dose on serum urate in people with gout. Arthritis & Rheumatology, 71(Suppl. 10), 0899. doi: 10.1002/art.41108

Chan, J., Stamp, L., Liebergreen, N., Ndukwe, H., Marra, C., & Treharne, G. (2019). Rheumatoid arthritis patients' perspectives on tapering of biologics: A qualitative study. Arthritis & Rheumatology, 71(Suppl. 10), 0877. doi: 10.1002/art.41108

Moors, J., Leask, M., Dalbeth, N., Stamp, L., Hindmarsh, J. H., & Merriman, T. (2019). Novel CETP variant associates with increased HDL and low LDL in Polynesian populations. In A. Finigan, P. Vakaoti, R. Richards & M. Schaaf (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices XVI. (pp. 23). Dunedin, New Zealand: The Pacific Islands Centre, University of Otago. Retrieved from https://www.otago.ac.nz/pacific

Moors, J., Leask, M., Dalbeth, N., Stamp, L., Hindmarsh, J. H., & Merriman, T. (2019). Pacific-specific CETP genetic variant associates with increased HDL and low LDL in Polynesian populations. Diabetologia, 62(Suppl. 1), (pp. S574-S575). [Abstract]

Treharne, G., Chan, J., Stamp, L., Liebergreen, N., Ndukwe, H., & Marra, C. (2019). A focus group study of patient perspectives on tapering biologic therapy for rheumatoid arthritis. In R. Masaryk & L. Valuš (Eds.), Proceedings of the 11th Biennial Conference of the International Society of Critical Health Psychology (ISCHP). Retrieved from https://ischp.net/past-conferences

2018

Journal - Research Article

Stamp, L. K., Chapman, P. T., Barclay, M. L., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2018). How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose. Arthritis Research & Therapy, 20, 255. doi: 10.1186/s13075-018-1755-0

Turner, R., Brennan, S. O., Ashby, L. V., Dickerhof, N., Hamzah, M. R., Pearson, J. F., Stamp, L. K., & Kettle, A. J. (2018). Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation. Journal of Biological Chemistry, 293(51), 19886-19898. doi: 10.1074/jbc.RA118.005237

Rolston, C. J., Conner, T. S., Stamp, L. K., Neha, T., Pitama, S., Fanning, N., … Hudson, B., Hegarty, R. M., & Treharne, G. J. (2018). Improving gout education from patients’ perspectives: A focus group study of Māori and Pākehā people with gout. Journal of Primary Health Care, 10(3), 194-200. doi: 10.1071/HC18010

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2018). Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial. Rheumatology, 57(12), 2183-2189. doi: 10.1093/rheumatology/key237

McKelvey, K. J., Millier, M. J., Doyle, T. C., Stamp, L. K., Highton, J., & Hessian, P. A. (2018). Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation. PLoS ONE, 13(8), e0202135. doi: 10.1371/journal.pone.0202135

Fatima, T., McKinney, C., Major, T. J., Stamp, L. K., Dalbeth, N., Iverson, C., Merriman, T. R., & Miner, J. N. (2018). The relationship between ferritin and urate levels and risk of gout. Arthritis Research & Therapy, 20, 179. doi: 10.1186/s13075-018-1668-y

Roberts, R. L., Wallace, M. C., Harrison, A. A., White, D., Dalbeth, N., Stamp, L. K., … Highton, J., Merriman, T. R., … Stebbings, S. M. (2018). Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin. PeerJ, 6, e5088. doi: 10.7717/peerj.5088

Krishnan, M., Major, T. J., Topless, R. K., Dewes, O., Yu, L., Thompson, J. M. D., … Stamp, L. K., … Wilcox, P., Grattan, D., … Merriman, T. R. (2018). Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand. Diabetologia, 61(7), 1603-1613. doi: 10.1007/s00125-018-4623-1

Ton, K. N. T., Cree, S. L., Gronert-Sum, S. J., Merriman, T. R., Stamp, L. K., & Kennedy, M. A. (2018). Multiplexed nanopore sequencing of HLA-B locus in Māori and Pacific Island samples. Frontiers in Genetics, 9, 152. doi: 10.3389/fgene.2018.00152

Stamp, L., Morillon, M. B., Taylor, W. J., Dalbeth, N., Singh, J. A., Lassere, M., & Christensen, R. (2018). Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis. Seminars in Arthritis & Rheumatism, 48, 293-301. doi: 10.1016/j.semarthrit.2018.02.009

Wright, D. F. B., Dalbeth, N., Phipps-Green, A. J., Merriman, T. R., Barclay, M. L., Drake, J., … Stamp, L. K. (2018). The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool. British Journal of Clinical Pharmacology, 84(5), 937-943. doi: 10.1111/bcp.13516

Gosling, A. L., Boocock, J., Dalbeth, N., Harré Hindmarsh, J., Stamp, L. K., Stahl, E. A., … Matisoo-Smith, E. A., & Merriman, T. R. (2018). Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand. Annals of the Rheumatic Diseases, 77(4), 571-578. doi: 10.1136/annrheumdis-2017-212416

Gath, M. E., Stamp, L. K., Aimer, P., Stebbings, S., & Treharne, G. J. (2018). Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators. Musculoskeletal Care, 16(1), 139-146. doi: 10.1002/msc.1227

Fanning, N., Merriman, T. R., Dalbeth, N., & Stamp, L. K. (2018). An association of smoking with serum urate and gout: A health paradox. Seminars in Arthritis & Rheumatism, 47(6), 825-842. doi: 10.1016/j.semarthrit.2017.11.004

Dalbeth, N., Pool, B., Chhana, A., Lin, J.-M., Tay, M. L., Tan, P., … Stamp, L. K., & Cornish, J. (2018). Lack of evidence that soluble urate directly influences bone remodelling: A laboratory and clinical study. Calcified Tissue International, 102(1), 73-84. doi: 10.1007/s00223-017-0328-6

Aimer, P., Stamp, L. K., Stebbings, S., Cameron, V., Kirby, S., & Treharne, G. J. (2018). Exploring perceptions of a rheumatoid arthritis-specific smoking cessation programme. Musculoskeletal Care, 16, 74-81. doi: 10.1002/msc.1209

Treharne, G. J., Richardson, A. C., Neha, T., Fanning, N., Janes, R., Hudson, B., … Pitama, S., & Stamp, L. K. (2018). Education preferences of people with gout: Exploring differences between indigenous and non-indigenous peoples from rural and urban locations. Arthritis Care & Research, 70(2), 260-267. doi: 10.1002/acr.23272

Journal - Research Other

Choi, H., Neogi, T., Stamp, L., Dalbeth, N., & Terkeltaub, R. (2018). Reply: To the editor. Arthritis & Rheumatology, 71(3), 481-482. doi: 10.1002/art.40742

Stamp, L. K., Merriman, T. R., & Singh, J. A. (2018). Expert opinion on emerging urate-lowering therapies. Expert Opinion on Emerging Drugs, 23(3), 201-209. doi: 10.1080/14728214.2018.1527899

Stamp, L. K., Wallace, M., Roberts, R. L., Frampton, C., Miner, J. N., Merriman, T. R., & Dalbeth, N. (2018). ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol. Drug Metabolism & Pharmacokinetics, 33(6), 241-242. doi: 10.1016/j.dmpk.2018.09.002

Choi, H., Neogi, T., Stamp, L., Dalbeth, N., & Terkeltaub, R. (2018). Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities trial and the associated Food and Drug Administration public safety alert. Arthritis & Rheumatology, 70(11), 1702-1709. doi: 10.1002/art.40583

Eason, C. T., Adams, S. L., Puddick, J., Romanazzi, D., Miller, M. R., King, N., … Hessian, P. A., Stamp, L. K., & Packer, M. A. (2018). Greenshell™ mussels: A review of veterinary trials and future research directions. Veterinary Sciences, 5(2), 36. doi: 10.3390/vetsci5020036

Major, T. J., Krishnan, M., Topless, R. K., Dewes, O., Thompson, J., de Zoysa, J., Stamp, L. K., … Wilcox, P., Grattan, D., … Merriman, T. R. (2018). Re: "Widespread prevalence of a CREBRF variant among Māori and Pacific children is associated with weight and height in early childhood". International Journal of Obesity, 42, 1389-1391. doi: 10.1038/s41366-018-0025-1

Barclay, M. L., & Stamp, L. K. (2018). Vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease [Invited]. Alimentary Pharmacology & Therapeutics, 47(4), 535-536. doi: 10.1111/apt.14465

Stamp, L. K., & Barclay, M. L. (2018). How to prevent allopurinol hypersensitivity reactions? Rheumatology, 57(1), i35-i41. doi: 10.1093/rheumatology/kex422

Stamp, L. K., Merriman, T., Frampton, C., Zhang, M., Wallace, M., Miner, J. N., & Dalbeth, N. (2018). Plasma oxypurinol as a measure of adherence in clinical trials. Annals of the Rheumatic Diseases, 77(2), 313-314. doi: 10.1136/annrheumdis-2016-210661

Conference Contribution - Published proceedings: Full paper

Viry, A., Raja, A. Y., Kirkbride, T. E., Choi, C., Stamp, L. K., Dalbeth, N., … Anderson, N. G., & Becce, F. (2018). Multi-energy spectral photon-counting CT in crystal-related arthropathies: Initial experience and diagnostic performance in vitro. Proceedings of the SPIE (Vol. 10573): Medical Imaging: Physics of Medical Imaging. 1057351. doi: 10.1117/12.2293458

Conference Contribution - Published proceedings: Abstract

Zaidi, F., Phipps-Green, A., Tausche, A.-K., So, A., Riches, P., Andres, M., … Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2018). Systematic genetic analysis of early-onset gout: ABCG2 141K is the strongest predictor. Arthritis & Rheumatology, 70(9, Suppl.), 2221. doi: 10.1002/art.40700

Zaidi, F., Allan, J., Gamble, G., Phipps-Green, A., Major, T. J., Mihov, B., … Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2018). Influence of diuretic-response sodium transporter genes on renal uric acid handling in response to frusemide. Arthritis & Rheumatology, 70(9, Suppl.), 1269. doi: 10.1002/art.40700

Yeo, E., Palmer, S., Chapman, P. T., Frampton, C., & Stamp, L. K. (2018). Serum urate levels in people with gout on dialysis: Are we achieving treatment targets? Arthritis & Rheumatology, 70(9, Suppl.), 2230. doi: 10.1002/art.40700

Stamp, L. K., Wallace, M., Roberts, R., Frampton, C., Miner, J., Merriman, T. R., & Dalbeth, N. (2018). ABCG2 rs2231142 Q141K and oxypurinol concentration in people with gout receiving allopurinol. Arthritis & Rheumatology, 70(9, Suppl.), 1266. doi: 10.1002/art.40700

Corkill, M., Topless, R., Worthington, A., Mitchell, R., Gregory, K., Stamp, L. K., … Merriman, T. R., & Dalbeth, N. (2018). Exploring the relationship between gout and diffuse idiopathic skeletal hyperostosis (DISH): An epidemiologic and genetic study. Arthritis & Rheumatology, 70(9, Suppl.), 2225. doi: 10.1002/art.40700

Stamp, L. K., Anderson, N., Becce, F., Rajeswari, M., Polson, M., Guyen, O., … Raja, A. (2018). Clinical utility of a multi-energy spectral CT in crystal arthritis. Arthritis & Rheumatology, 70(9, Suppl.), 2204. doi: 10.1002/art.40700

Narang, R. K., Topless, R., Cadzow, M., Gamble, G., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2018). Interactions between serum urate-associated genetic variants and sex on gout risk in a European population. Arthritis & Rheumatology, 70(9, Suppl.), 2224. doi: 10.1002/art.40700

Marsman, J., Millier, M. J., Highton, J., Stamp, L. K., & Hessian, P. A. (2018). Transcriptional profiling of the subcutaneous rheumatoid nodule: An insight into pathogenic mechanisms and cellular content. Arthritis & Rheumatology, 70(9, Suppl.), 929. doi: 10.1002/art.40700

Klück, V., van Deuren, R. C., Shaukat, A., Cleophas, M., Crisan, T. O., Dalbeth, N., Stamp, L. K., … Merriman, T. R., & Joosten, L. A. B. (2018). Genetic variants identify interleukin 37 as an important anti-inflammatory cytokine in gout in humans. Arthritis & Rheumatology, 70(9, Suppl.), 2248. doi: 10.1002/art.40700

Fanning, N., Millier, M. J., Highton, J., Frampton, C., Hessian, P. A., & Stamp, L. K. (2018). Plasma IL-23 and IL-25 predict response to anti-TNF-α therapy in rheumatoid arthritis. Arthritis & Rheumatology, 70(9, Suppl.), 2879. doi: 10.1002/art.40700

Fanning, N., Merriman, T. R., Phipps-Green, A., Pearson, J., Topless, R., Cadzow, M., … Dalbeth, N., & Stamp, L. K. (2018). An ancestral-specific interaction of TRIM46 with a past-history of smoking may influence gout risk. Arthritis & Rheumatology, 70(9, Suppl.), 2231. doi: 10.1002/art.40700

Dalbeth, N., Billington, K., Doyle, A., Frampton, C., Tan, P., Allan, J., … Stamp, L. K. (2018). Allopurinol dose escalation slows progression of CT bone erosion in people with gout: Imaging sub-study of a randomized control trial. Arthritis & Rheumatology, 70(9, Suppl.), 2969. doi: 10.1002/art.40700

Stamp, L. K., Chapman, P. T., Hudson, B., Hamilton, G., & Judd, A. (2018). The challenges of managing gout in primary care: Results of a best practice audit. Arthritis & Rheumatology, 70(9, Suppl.), 1265. doi: 10.1002/art.40700

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2018). Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomized controlled trial. Arthritis & Rheumatology, 70(9, Suppl.), 2229. doi: 10.1002/art.40700

Shaukat, A., Gosling, A., Bixley, M., Phipps-Green, A., Major, T. J., Cadzow, M., … Stamp, L. K., Matisoo-Smith, E., … Merriman, T. R. (2018). Evaluating a causal role of mitochondrial variation in the development of gout. Arthritis & Rheumatology, 70(9, Suppl.), 1278. doi: 10.1002/art.40700

Stamp, L., Chapman, P., Barclay, M., Horne, A., Tan, P., Drake, J., & Dalbeth, N. (2018). Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomized controlled trial. Scandinavian Journal of Rheumatology, 47(Suppl. 129), (pp. 40-41). doi: 10.1080/03009742.2018.1487639

Stamp, L., Chapman, P., Hudson, B., Hamilton, G., & Judd, A. (2018). The challenges of managing gout in primary care: Results of a best practice audit. Scandinavian Journal of Rheumatology, 47(Suppl. 129), (pp. 6). doi: 10.1080/03009742.2018.1487639

Klück, V., Crisan, T., Cleophas, M., Keating, S., Novakovic, B., Dalbeth, N., Stamp, L., Phipps-Green, A., Black, M., … Merriman, T., & Joosten, L. (2018). DNA methylation of SOCS3 as a possible mechanism for persistent urate induced inflammation. Annals of the Rheumatic Diseases, 77(Suppl. 2), (pp. 887-888). doi: 10.1136/annrheumdis-2018-eular.6281

Merriman, T. R., Shaukat, A., Gosling, A., Bixley, M., Dalbeth, N., Stamp, L., Matisoo-Smith, E., … Riches, P. (2018). Testing for a causal role of mitochondrial variation in the development of gout. Annals of the Rheumatic Diseases, 77(Suppl. 2), (pp. 666). doi: 10.1136/annrheumdis-2018-eular.5017

Conference Contribution - Poster Presentation (not in published proceedings)

Shaukat, A., Gosling, A., Bixley, M., Phipps-Green, A., Major, T., Cadzow, M., … Stamp, L., Matisoo-Smith, E., … Merriman, T. (2018, September). Evaluating a causal role of mitochondrial variation in the development of gout. Poster session presented at the Otago Spotlight Symposium on Infectious Disease, Wellington, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Hudson, B., Williman, J. A., Stamp, L. K., Alchin, J. S., Hooper, G. J., Mangin, D., Thompson, B. F., & Toop, L. (2018, September). Nortriptyline in knee osteoarthritis (NortIKA Study): A randomised controlled trial. Verbal presentation at the General Practice and Primary Care Research Weekend, Hanmer Springs, New Zealand.

2017

Journal - Research Article

Stamp, L. K., Morillon, M. B., Taylor, W. J., Dalbeth, N., Singh, J. A., Lassere, M., & Christensen, R. (2017). Variability in the reporting of serum urate and flares in gout clinical trials: Need for minimum reporting requirements. Journal of Rheumatology, 45(3), 170911. doi: 10.3899/jrheum.170911

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: A post hoc analysis of a randomized controlled trial. Arthritis Research & Therapy, 19(1), 283. doi: 10.1186/s13075-017-1491-x

Millier, M. J., Stamp, L. K., & Hessian, P. A. (2017). Digital-PCR for gene expression: Impact from inherent tissue RNA degradation. Scientific Reports, 7, 17235 . doi: 10.1038/s41598-017-17619-0

McQueen, F. M., Chapman, P., Pollock, T., D’Souza, D., Lee, A. C., Dalbeth, N., Stamp, L., … Doyle, A. (2017). Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis. Arthritis Research & Therapy, 19, 241. doi: 10.1186/s13075-017-1433-7

Stamp, L. K., Haslett, J., Chapman, P., O'Donnell, J., Raja, R., Rothwell, A., Frampton, C., & Hooper, G. (2017). Rates of joint replacement surgery in New Zealand, 1999-2015: A comparison of rheumatoid arthritis and osteoarthritis. Journal of Rheumatology, 44(12), 1823-1827. doi: 10.3899/jrheum.170551

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). Allopurinol dose escalation to achieve serum urate below 6 mg/dL: An open-label extension study. Annals of the Rheumatic Diseases, 76(12), 2065-2070. doi: 10.1136/annrheumdis-2017-211873

Elhai, M., Meune, C., Boubaya, M., Avouac, J., Hachulla, E., Balbir-Gurman, A., … Stamp, L., … on behalf of EUSTAR group. (2017). Mapping and predicting mortality from systemic sclerosis. Annals of the Rheumatic Diseases, 76(11), 1897-1905. doi: 10.1136/annrheumdis-2017-211448

Wright, S., Chapman, P. T., Frampton, C., O'Donnell, J. L., Raja, R., & Stamp, L. K. (2017). Management of gout in a hospital setting: A lost opportunity. Journal of Rheumatology, 44(10), 1493-1498. doi: 10.3899/jrheum.170387

Rasheed, H., Stamp, L. K., Dalbeth, N., & Merriman, T. R. (2017). Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout. Arthritis Research & Therapy, 19, 161. doi: 10.1186/s13075-017-1369-y

Houlder, E. L., Millier, M. J., Highton, J., Gwynne-Jones, D., Stamp, L. K., & Hessian, P. A. (2017). Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. Clinical & Experimental Rheumatology, 35(6), 943-947.

Cleophas, M. C., Joosten, L. A., Stamp, L. K., Dalbeth, N., Woodward, O. M., & Merriman, T. R. (2017). ABCG2 polymorphisms in gout: Insights into disease susceptibility and treatment approaches. Pharmacogenomics & Personalized Medicine, 10, 129-142. doi: 10.2147/pgpm.s105854

Kannangara, D. R. W., Graham, G. G., Wright, D. F. B., Stocker, S. L., Portek, I., Pile, K. D., Barclay, M. L., … Stamp, L. K., & Day, R. O. (2017). Individualising the dose of allopurinol in patients with gout. British Journal of Clinical Pharmacology, 83(9), 2015-2026. doi: 10.1111/bcp.13307

Dalbeth, N., Allan, J., Gamble, G. D., Phipps-Green, A., Flynn, T. J., Mihov, B., … Stamp, L. K., & Merriman, T. R. (2017). Influence of genetic variants on renal uric acid handling in response to frusemide: An acute intervention study. RMD Open, 3(1), e000424. doi: 10.1136/rmdopen-2016-000424

Tanner, C., Boocock, J., Stahl, E. A., Dobbyn, A., Mandal, A. K., Cadzow, M., Phipps-Green, A. J., Topless, R. K., … Stamp, L. K., … Merriman, T. R. (2017). Population specific resequencing associates the ATP binding cassette subfamily C member 4 (ABCC4) gene with gout in New Zealand Māori and Pacific men. Arthritis & Rheumatology, 69(7), 1461-1469. doi: 10.1002/art.40110

Vazirpanah, N., Kienhorst, L. B. E., Van Lochem, E., Wichers, C., Rossato, M., Shiels, P. G., … Stamp, L. K., Merriman, T. R., … Broen, J. C. A. (2017). Patients with gout have short telomeres compared with healthy participants: Association of telomere length with flare frequency and cardiovascular disease in gout. Annals of the Rheumatic Diseases, 76(7), 1309-1315. doi: 10.1136/annrheumdis-2016-210538

Stamp, L. K., Chapman, P. T., Barclay, M. L., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout. Annals of the Rheumatic Diseases, 76(9), 1522-1528. doi: 10.1136/annrheumdis-2016-210872

Batt, C., Fanning, N., Drake, J., Frampton, C., Gearry, R. B., & Stamp, L. K. (2017). Fructose malabsorption in people with and without gout: A case-control study. Seminars in Arthritis & Rheumatism, 47(2), 257-263. doi: 10.1016/j.semarthrit.2017.03.018

He, W., Phipps-Green, A., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2017). Population-specific association between ABCG2 variants and tophaceous disease in people with gout. Arthritis Research & Therapy, 19(1), 43. doi: 10.1186/s13075-017-1254-8

Nakayama, A., Nakaoka, H., Yamamoto, K., Sakiyama, M., Shaukat, A., Toyoda, Y., … Stamp, L. K., … Merriman, T. R., & Matsuo, H. (2017). GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Annals of the Rheumatic Diseases, 76(5), 869-877. doi: 10.1136/annrheumdis-2016-209632

Ogdie, A., Taylor, W. J., Neogi, T., Fransen, J., Jansen, T. L., Schumacher, H. R., … Stamp, L. K., … Dalbeth, N. (2017). Performance of ultrasound in the diagnosis of gout in a multicenter study: Comparison with monosodium urate monohydrate crystal analysis as the gold standard. Arthritis & Rheumatology, 69(2), 429-438. doi: 10.1002/art.39959

Wright, D. F. B., Doogue, M. P., Barclay, M. L., Chapman, P. T., Cross, N. B., Irvine, J. H., & Stamp, L. K. (2017). A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis. European Journal of Clinical Pharmacology, 73, 71-78. doi: 10.1007/s00228-016-2133-y

Farquhar, H. J., McGettigan, B., Chapman, P. T., O'Donnell, J. L., Frampton, C., & Stamp, L. K. (2017). Incidence of anti-neutrophil cytoplasmic antibody-associated vasculitis before and after the February 2011 Christchurch Earthquake. Internal Medicine Journal, 47(1), 57-61. doi: 10.1111/imj.13246

Stamp, L., & Dalbeth, N. (2017). Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution. Seminars in Arthritis & Rheumatism, 46(4), 457-464. doi: 10.1016/j.semarthrit.2016.07.015

Aimer, P., Treharne, G. J., Stebbings, S., Frampton, C., Cameron, V., Kirby, S., & Stamp, L. K. (2017). Efficacy of a rheumatoid arthritis-specific smoking cessation programme: A pilot randomized controlled trial. Arthritis Care & Research, 69(1), 28-37. doi: 10.1002/acr.22960

Roberts, R. L., Wallace, M. C., Phipps-Green, A. J., Topless, R., Drake, J. M., Tan, P., … Merriman, T. R., & Stamp, L. K. (2017). ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout. Pharmacogenomics Journal, 17, 201-203. doi: 10.1038/tpj.2015.101

Muniraj, N., Stamp, L. K., Badiei, A., Hegde, A., Cameron, V., & Bhatia, M. (2017). Hydrogen sulfide acts as a pro-inflammatory mediator in rheumatic disease. International Journal of Rheumatic Diseases, 20(2), 182-189. doi: 10.1111/1756-185x.12472

Journal - Research Other

Dalbeth, N., Stamp, L. K., & Merriman, T. R. (2017). The genetics of gout: Towards personalised medicine? BMC Medicine, 15(1), 108. doi: 10.1186/s12916-017-0878-5

Stamp, L. K. (2017). Major unanswered questions in the clinical gout field. Current Opinion in Rheumatology, 29(2), 171-177. doi: 10.1097/bor.0000000000000367

Journal - Professional & Other Non-Research Articles

Dalbeth, N., Bardin, T., Doherty, M., Lioté, F., Richette, P., Saag, K. G., … Stamp, L. K., … Terkeltaub, R. (2017). Discordant American College of Physicians and international rheumatology guidelines for gout management: Consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN). Nature Reviews Rheumatology, 13, 561-568. doi: 10.1038/nrrheum.2017.126

Neogi, T., Dalbeth, N., Stamp, L., Castelar, G., Fitzgerald, J., Gaffo, A., … Edwards, N. L. (2017). Renal dosing of allopurinol results in suboptimal gout care. Annals of the Rheumatic Diseases, 76(1), e1. doi: 10.1136/annrheumdis-2016-210352

Conference Contribution - Published proceedings: Abstract

Shaukat, A., Phipps-Green, A., Dalbeth, N., Stamp, L., & Merriman, T. (2017). Association of genetic variants in AAT encoded SERPINA1 gene with gout in Europeans and Polynesian. Proceedings of the Annual Conference of the Genetics Society of Australasia (GSA) with the New Zealand Society for Biochemistry and Molecular Biology (NZSBMB). 549. Retrieved from http://gen2017.w.events4you.currinda.com

Phipps-Green, A. J., Wrigley, R., Boocock, J., Riches, P., Tausche, A.-K., Radstake, T. R., … Stamp, L. K., … Merriman, T. R. (2017). Pleiotropic effect of ABCG2 in gout. Proceedings of the Annual Conference of the Genetics Society of Australasia (GSA) with the New Zealand Society for Biochemistry and Molecular Biology (NZSBMB). 546. Retrieved from http://gen2017.w.events4you.currinda.com

Major, T. J., Cadzow, M. J., Merriman, M. E., Phipps-Green, A. J., Topless, R. K. G., Abhishek, A., … McCormick, S. P. A., … Walker, R. J., … Stamp, L. K., & Merriman, T. R. (2017). Genome-wide association study of gout in 111,098 people of european ancestry. Proceedings of the Annual Conference of the Genetics Society of Australasia (GSA) with the New Zealand Society for Biochemistry and Molecular Biology (NZSBMB). 547. Retrieved from http://gen2017.w.events4you.currinda.com

Wiles, A., Kazantseva, M., Li, K., Williams, M., Bowie, S., Jo, S., Millier, M., Hessian, P., Stamp, L., Baird, M. A., Slatter, T., & Braithwaite, A. (2017). The presence of Δ133p53β in the autoimmune disease rheumatoid arthritis. Proceedings of the 3rd International p53 Isoform Conference. P10. Retrieved from http://www.uib.no/en/ccbio

Shaukat, A., Dalbeth, N., Stamp, L., & Merriman, T. (2017). Association of genetic variants in Alpha1-antitrypsin encoded SERPINA1 gene with gout risk in European and Polynesian ancestral groups. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 83). Retrieved from http://www.otago.ac.nz/graduate-research/scholarships/otago643219.html

Wright, D. F. B., Phipps-Green, A., Merriman, T. R., Barclay, M. L., Dalbeth, N., & Stamp, L. K. (2017). The influence of ABCG2 genotype on allopurinol dose predictions. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 55). Retrieved from http://www.asceptasm.com/

Merriman, T. R., Cadzow, M., Merriman, M., Phipps-Green, A., Topless, R., Abhishek, A., … McCormick, S., … Walker, R., … Stamp, L., & Flynn, T. (2017). A genome-wide association study of gout in people of European ancestry. Annals of the Rheumatic Diseases, 76(Suppl. 2), (pp. 383). doi: 10.1136/annrheumdis-2017-eular.5634

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). Allopurinol dose escalation to achieve serum urate below 6mg/Dl: An open label extension study. Arthritis & Rheumatology, 69(Suppl. 10), 1105. doi: 10.1002/art.40321

Stamp, L. K., Morillon, M., Taylor, W., Dalbeth, N., Lassere, M., Singh, J. A., & Christensen, R. (2017). Association between serum urate as a surrogate endpoint and flares in people with gout: An ecological study based on a systematic review of trials and open label extensions. Arthritis & Rheumatology, 69(Suppl. 10), 2845. doi: 10.1002/art.40321

Wallace, M., Roberts, R., Nanavati, P., Miner, J. N., Dalbeth, N., Topless, R., Merriman, T. R., & Stamp, L. K. (2017). Association between ABCG2 rs2231142 and poor response to allopurinol: Replication and meta-analysis. Arthritis & Rheumatology, 69(Suppl. 10), 1106. doi: 10.1002/art.40321

McQueen, F. M., Chapman, P. T., Pollock, T., D'Souza, D., Lee, A., Dalbeth, N., Stamp, L. K., … Doyle, A. (2017). Changes in clinical disease activity are associated with changes in the total MRI inflammation score in rheumatoid arthritis patients who are escalating therapy in a treat-to-target (T2T) regimen. Arthritis & Rheumatology, 69(Suppl. 10), 1992. doi: 10.1002/art.40321

Shaukat, A., Jansen, T., Janssen, M., Joosten, L. A. B., Radstake, T., Riches, P., … Stamp, L. K., & Merriman, T. R. (2017). Replication of genetic association of peroxisome proliferator-activated receptor gamma-1B with gout in a New Zealand Polynesian sample set. Arthritis & Rheumatology, 69(Suppl. 10), 1127. doi: 10.1002/art.40321

Vincent, Z., Phipps-Green, A., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2017). Population-specific factors associated with fractional excretion of uric acid. Arthritis & Rheumatology, 69(Suppl. 10), 2061. doi: 10.1002/art.40321

Taylor, W. J., Dalbeth, N., Saag, K., Singh, J. A., Rahn, E. J., Mudano, A. S., … Stamp, L. K., … Gaffo, A. L. (2017). Patients with gout consider zero flares over the previous six or twelve months necessary for a remission state. Arthritis & Rheumatology, 69(Suppl. 10), 350. doi: 10.1002/art.40321

Stebbings, S., Wallace, M., Harrison, A. A., Dalbeth, N., White, D., Stamp, L. K., … Highton, J. (2017). In ankylosing spondylitis/axial spondyloarthritis smoking is associated with a dose related elevation in CRP, worse disease activity and worse quality of life over one year. Arthritis & Rheumatology, 69(Suppl. 10), 2506. doi: 10.1002/art.40321

Dalbeth, N., de Kwant, J., Gamble, G., Phipps-Green, A., Horne, A., Stamp, L. K., & Merriman, T. R. (2017). Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load. Arthritis & Rheumatology, 69(Suppl. 10), 1108. doi: 10.1002/art.40321

Merriman, T. R., Cadzow, M., Merriman, M. E., Phipps-Green, A., Topless, R., Abhishek, A., … McCormick, S., … Walker, R., … Stamp, L. K., & Major, T. (2017). A genome-wide association study of gout in people of European ancestry. Arthritis & Rheumatology, 69(Suppl. 10), 1104. doi: 10.1002/art.40321

Matsuo, H., Nakayama, A., Nakaoka, H., Yamamoto, K., Sakiyama, M., Shaukat, A., … Stamp, L. K., … Merriman, T. R., & Shinomiya, M. (2017). Genome-wide association study of clinically-ascertained gout and subtypes identifies multiple susceptibility loci including transporter genes. Arthritis & Rheumatology, 69(Suppl. 10), 170. doi: 10.1002/art.40321

Matsuo, H., Nakayama, A., Nakaoka, H., Yamamoto, K., Sakiyama, M., Shaukat, A., … Stamp, L., … Merriman, T., … Japan Gout Consortium. (2017). Genome-wide association study of clinically-defined gout and subtypes identifies multiple susceptibility loci including transporter genes. Proceedings of the American Society of Human Genetics (ASHG) Annual Meeting. 1834. Retrieved from http://www.ashg.org/2017meeting/

Grainger, R., Townsley, H., Harrison, A., Stebbings, S., & Stamp, L. (2017). What do people with rheumatoid arthritis want to know to be confident to perform their own joint counts? Internal Medicine Journal, 47(Suppl. 2), (pp. 31). doi: 10.1111/imj.13426

Stebbings, S., Wallace, M., Harrison, A., Dalbeth, N., White, D., Stamp, L., … Highton, J. (2017). Smoking and spondyloarthritis: Quit while you can? Internal Medicine Journal, 47(Suppl. 2), (pp. 10). doi: 10.1111/imj.13426

Harun, S., Chambers, S., Hooper, G., Frampton, C., Chapman, P., Mohammed, R., … Haslett, J., Nolan, I., & Stamp, L. (2017). Prosthetic joint infections in Canterbury, New Zealand: A comparison of individuals with and without a rheumatic disease. Internal Medicine Journal, 47(Suppl. 2), (pp. 21). doi: 10.1111/imj.13426

Merriman, T., Boocock, J., Dalbeth, N., Stamp, L., Stahl, E., Choi, H., Matisoo-Smith, L., & Gosling, A. (2017). Mitochondrial genetic variation, copy number and susceptibility to gout in the New Zealand Polynesian (Māori and Pacific) population. Internal Medicine Journal, 47(Suppl. 2), (pp. 8). doi: 10.1111/imj.13426

Batt, C., Fanning, N., Drake, J., Frampton, C., Gearry, R., & Stamp, L. (2017). Fructose malabsorption in people with gout and effect of allopurinol: Implications for diet. Internal Medicine Journal, 47(Suppl. 2), (pp. 8). doi: 10.1111/imj.13426

Grainger, R., Townsley, H., Harrison, A., Stebbings, S., Stamp, L., & Taylor, W. (2017). Consensus discussion increases the concordance of joint counts performed by people with rheumatoid arthritis with joint counts performed by rheumatologists. Internal Medicine Journal, 47(Suppl. 2), (pp. 31). doi: 10.1111/imj.13426

McQueen, F., Chapman, P., Pollock, T., D'Souza, D., Lee, A., Dalbeth, N., Stamp, L., … Doyle, A. (2017). Changes in the total MRI inflammation score as associated with changes in clinical disease activity in RA patients who are escalating therapy in a treat-to-target (T2T) regimen. Internal Medicine Journal, 47(Suppl. 2), (pp. 8-9). doi: 10.1111/imj.13426

O'Donnell, J., Liu, J., Keating, P., Hock, B., Spellerberg, M., Barclay, M., & Stamp, L. (2017). Anti-drug antibodies (ADA): Assay performance in patients treated for inflammatory bowel and rheumatic disease with biodrugs, adalimumab and infliximab. Internal Medicine Journal, 47(Suppl. 2), (pp. 15). doi: 10.1111/imj.13426

2016

Journal - Research Article

Cadzow, M., Merriman, T. R., Boocock, J., Dalbeth, N., Stamp, L. K., Black, M. A., … Wilcox, P. L. (2016). Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A. BMC Medical Genetics, 17, 80. doi: 10.1186/s12881-016-0341-z

Towiwat, P., Doyle, A. J., Gamble, G. D., Tan, P., Aati, O., Horne, A., Stamp, L. K., & Dalbeth, N. (2016). Urate crystal deposition and bone erosion in gout: 'Inside-out' or 'outside-in'? A dual-energy computed tomography study. Arthritis Research & Therapy, 18(1), 208. doi: 10.1186/s13075-016-1105-z

Stamp, L. K., Haslett, J., Frampton, C., White, D., Gardner, D., Stebbings, S., … Grainger, R., … Dalbeth, N. (2016). The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand. Internal Medicine Journal, 46(9), 1075-1080. doi: 10.1111/imj.13173

Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016). Gout. Lancet, 388(10055), 2039-2052. doi: 10.1016/S0140-6736(16)00346-9

Rasheed, H., Phipps-Green, A. J., Topless, R., Smith, M. D., Hill, C., Lester, S., … van Rij, A., Jones, G. T., McCormick, S. P., Harrison, A. A., Stamp, L. K., … Merriman, T. R. (2016). Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. Rheumatology, 55(8), 1421-1430. doi: 10.1093/rheumatology/kew057

Dalbeth, N., Schumacher, H. R., Fransen, J., Neogi, T., Jansen, T. L., Brown, M., … Stamp, L. K., … Taylor, W. J. (2016). Survey definitions of gout for epidemiological studies: Comparison with crystal identification as the gold standard. Arthritis Care & Research, 68(12), 1894-1898. doi: 10.1002/acr.22896

Mitnala, S., Phipps-Green, A., Franklin, C., Horne, A., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2016). Clinical and genetic features of diuretic-associated gout: A case-control study. Rheumatology, 55(7), 1172-1176. doi: 10.1093/rheumatology/kew018

Rasheed, H., McKinney, C., Stamp, L. K., Dalbeth, N., Topless, R. K., Day, R., … Merriman, T. R. (2016). The toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and Polynesian sample sets. PLoS ONE, 11(1), e0147939. doi: 10.1371/journal.pone.0147939

Kannangara, D. R. W., Phipps-Green, A. J., Dalbeth, N., Stamp, L. K., Williams, K. M., Graham, G. G., … Merriman, T. R. (2016). Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate. Annals of the Rheumatic Diseases, 75, 1363-1366. doi: 10.1136/annrheumdis-2015-208111

Taylor, W. J., Fransen, J., Dalbeth, N., Neogi, T., Schumacher, H. R., Brown, M., … Stamp, L. K., … Jansen, T. L. (2016). Diagnostic arthrocentesis for suspicion of gout is safe and well tolerated. Journal of Rheumatology, 43(1), 150-153. doi: 10.3899/jrheum.150684

Bayat, S., Aati, O., Rech, J., Sapsford, M., Cavallaro, A., Lell, M., … Stamp, L. K., … Dalbeth, N. (2016). Development of a dual energy computed tomography scoring system for measurement of urate deposition in gout. Arthritis Care & Research, 68(6), 769-775. doi: 10.1002/acr.22754

Wright, D. F. B., Duffull, S. B., Merriman, T. R., Dalbeth, N., Barclay, M. L., & Stamp, L. K. (2016). Predicting allopurinol response in patients with gout. British Journal of Clinical Pharmacology, 81(2), 277-289. doi: 10.1111/bcp.12799

Stamp, L. K., Chapman, P. T., & Palmer, S. C. (2016). Allopurinol and kidney function: An update. Joint Bone Spine, 83, 19-24. doi: 10.1016/j.jbspin.2015.03.013

Stamp, L. K., Day, R. O., & Yun, J. (2016). Allopurinol hypersensitivity: Investigating the cause and minimizing the risk. Nature Reviews Rheumatology, 12, 235-242. doi: 10.1038/nrrheum.2015.132

Fatima, T., Altaf, S., Phipps-Green, A., Topless, R., Flynn, T. J., Stamp, L. K., … Merriman, T. R. (2016). Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout. Rheumatology International, 36(2), 255-261. doi: 10.1007/s00296-015-3370-6

Hock, B. D., Stamp, L. K., Hayman, M. W., Keating, P. E., Helms, E. T. J., & Barclay, M. L. (2016). Development of an ELISA-based competitive binding assay for the analysis of drug concentration and anti-drug antibody levels in patients receiving adalimumab or infliximab. Therapeutic Drug Monitoring, 38(1), 32-41. doi: 10.1097/ftd.0000000000000229

Aimer, P., Stamp, L. K., Stebbings, S., Cameron, V., Kirby, S., Croft, S., & Treharne, G. J. (2016). Developing a tailored smoking cessation intervention for rheumatoid arthritis patients. Musculoskeletal Care, 14(1), 2-14. doi: 10.1002/msc.1106

Taylor, W. J., Fransen, J., Dalbeth, N., Neogi, T., Schumacher, H. R., Brown, M., … Stamp, L. K., … Jansen, T. L. (2016). Performance of classification criteria for gout in early and established disease. Annals of the Rheumatic Diseases, 75, 178-182. doi: 10.1136/annrheumdis-2014-206364

Phipps-Green, A. J., Merriman, M. E., Topless, R., Altaf, S., Montgomery, G. W., Franklin, C., Jones, G. T., van Rij, A. M., … Stamp, L. K., … Merriman, T. R. (2016). Twenty-eight loci that influence serum urate levels: Analysis of association with gout. Annals of the Rheumatic Diseases, 75, 124-130. doi: 10.1136/annrheumdis-2014-205877

Journal - Research Other

Morillon, M. B., Stamp, L., Taylor, W., Fransen, J., Dalbeth, N., Singh, J. A., … Lassere, M. (2016). Using serum urate as a validated surrogate end point for flares in patients with gout: Protocol for a systematic review and meta-regression analysis. BMJ Open, 6(9), e012026 . doi: 10.1136/bmjopen-2016-012026

Gaffo, A. L., Mikuls, T. R., Stamp, L. K., & Neogi, T. (2016). Allopurinol dose reductions based on creatinine alert redesign system. American Journal of Medicine, 129(7), e95. doi: 10.1016/j.amjmed.2015.12.035

Robinson, P. C., & Stamp, L. K. (2016). The management of gout: Much has changed. Australian Family Physician, 45(5), 299-302.

Journal - Professional & Other Non-Research Articles

de Lautour, H., Taylor, W. J., Adebajo, A., Alten, R., Burgos-Vargas, R., Chapman, P., … Stamp, L. K., … Dalbeth, N. (2016). Development of preliminary remission criteria for gout using Delphi and 1000Minds® consensus exercises. Arthritis Care & Research, 68(5), 667-672. doi: 10.1002/acr.22741

Saito, Y., Stamp, L. K., Caudle, K. E., Hershfield, M. S., McDonagh, E. M., Callaghan, J. T., … Lee, M. T. M. (2016). Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clinical Pharmacology & Therapeutics, 99(1), 36-37. doi: 10.1002/cpt.161

Conference Contribution - Published proceedings: Abstract

Keating, P., Hock, B., Barclay, M., Stamp, L., Spellerberg, M., & O'Donnell, J. (2016). Application of an ELISA based competitive binding assay to measure concentration of anti-TNF biologics and neutralising anti-drug antibodies in the clinical laboratory. European Journal of Immunology, 46(Suppl. 1), (pp. 1033). doi: 10.1002/eji.201670200

Shaukat, A., Phipps-Green, A., Dalbeth, N., Stamp, L., Harré Hindmarsh, J., & Merriman, T. (2016). Genetic association of inflammatory gene PPARGC1B with gout in New Zealand Polynesian and European groups. In A. Finigan, M. Taumoepeau, I. Iati, P. Vakaoti & R. Richards (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices XIII. (pp. 17). Dunedin, New Zealand: Pacific Islands Centre, University of Otago. [Abstract]

Fatima, T., McKinney, C., Stamp, L. K., Dalbeth, N., Iverson, C., Merriman, T. R., & Miner, J. N. (2016). Ferritin levels are associated with serum urate and gout: A role of iron metabolism in gout? In A. Finigan, M. Taumoepeau, I. Iati, P. Vakaoti & R. Richards (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices XIII. (pp. 6). Dunedin, New Zealand: Pacific Islands Centre, University of Otago. [Abstract]

Wright, D. F. B., Doogue, M. P., Barclay, M. L., Chapman, P. T., Cross, N. B., Irvine, J. H., & Stamp, L. K. (2016). Predicting oxypurinol exposure in patients receiving intermittent haemodialysis. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 48). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/

Pan, S., Stamp, L., & Duffull, S. (2016). Delineation of the treatment effect of methotrexate when used in combination therapy for rheumatoid arthritis. Proceedings of the Twenty-Fifth Annual Meeting of the Population Approach Group in Europe (PAGE). (pp. 317). Retrieved from http://www.page-meeting.org/

Conference Contribution - Poster Presentation (not in published proceedings)

Shaukat, A., Phipps-Green, A., Dalbeth, N., Stamp, L., Hindmarsh, J. H., & Merriman, T. (2016, August-September). Genetic association of inflammatory gene PPARGC1B with gouty arthritis in a New Zealand population. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Shaukat, A., Leaupepe, K., Phipps-Green, A., Dalbeth, N., Stamp, L., Hindmarsh, J. H., & Merriman, T. (2016, August-September). Genetic correlation between interleukin 23 receptor (IL23R) three variants (rs7517847, rs11209026 and rs11465804) and gout susceptibility in a New Zealand population. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Bixley, M. J., Flynn, T. J., Topless, R., Dalbeth, N., Stamp, L. K., Wilson, J., & Merriman, T. R. (2016, August-September). Runs of homozygosity in Eastern and Western Polynesians and metabolic disease. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Merriman, T., Boocock, J., Flynn, T., Tanner, C., Fatima, T., Choi, H., … Stamp, L., … Stahl, E. (2016, August-September). Identification of biologically informative uncommon genetic variants in urate control by re-sequencing in extreme phenotype. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Towiwat, P., Doyle, A., Gamble, G., Tan, P., Aati, O., Horne, A., Stamp, L., & Dalbeth, N. (2016, August). Urate crystal deposition and bone erosion in gout: Inside-out or outside-in? A dual energy computed tomography study. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Napier, New Zealand.

Stamp, L., Chapman, P., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2016, August). The safety and efficacy of allopurinol dose escalation in people with gout: A randomised controlled trial. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Napier, New Zealand.

Aimer, P., Stamp, L., Stebbings, S., Cameron, V., Kirby, S., & Treharne, G. (2016, August). Exploring perceptions of a rheumatoid arthritis specific smoking cessation programme. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Napier, New Zealand.

Richardson, A., Stamp, L., Neha, T., Fanning, N., Rolston, C., Pitama, S., … Judd, A., & Treharne, G. (2016, August). Patient preferences in gout education: Differences between rural and urban, Māori and non-Māori populations in New Zealand. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Napier, New Zealand.

Farquhar, H., McGettigan, B., O'Donnell, J., Chapman, P., Frampton, C., & Stamp, L. (2016, August). Incidence of ANCA associated vasculitis before and after the February 2011 Christchurch earthquake. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Napier, New Zealand.

Stamp, L., Haslett, J., Frampton, C., White, D., Gardner, D., Stebbings, S., … Grainger, R., … Dalbeth, N. (2016, August). The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Napier, New Zealand.

Stamp, L. (2016, August). Joint injection techniques. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

Stamp, L., Betty, B., Chapman-Smith, P., & Petrie, J. (2016, August). Rheumatology forum: Gout, biologics, stem cells, early intervention in RA. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

2015

Journal - Research Article

Stamp, L. K., Chapman, P. T., Francis, J., Beckert, L., Frampton, C., Watts, R. A., & O'Donnell, J. L. (2015). Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand. Arthritis Research & Therapy, 17, 333. doi: 10.1186/s13075-015-0852-6

Topless, R. K., Flynn, T. J., Cadzow, M., Stamp, L. K., Dalbeth, N., Black, M. A., & Merriman, T. R. (2015). Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal women. Frontiers in Genetics, 6, 313. doi: 10.3389/fgene.2015.00313

Kennedy, N., Chambers, S. T., Nolan, I., Gallagher, K., Werno, A., Browne, M., & Stamp, L. K. (2015). Native joint septic arthritis: Epidemiology, clinical features, and microbiological causes in a New Zealand population. Journal of Rheumatology, 42(12), 2392-2397. doi: 10.3899/jrheum.150434

McKinney, C., Stamp, L. K., Dalbeth, N., Topless, R. K., Day, R. O., Kannangara, D. R. W., … Merriman, T. R. (2015). Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Research & Therapy, 17, 288. doi: 10.1186/s13075-015-0802-3

Pan, S., Korell, J., Stamp, L. K., & Duffull, S. B. (2015). Simplification of a pharmacokinetic model for red blood cell methotrexate disposition. European Journal of Clinical Pharmacology, 71(12), 1509-1516. doi: 10.1007/s00228-015-1951-7

Dalbeth, N., Phipps-Green, A., House, M. E., Gamble, G. D., Horne, A., Stamp, L. K., & Merriman, T. R. (2015). Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout. Arthritis Research & Therapy, 17(1), 263. doi: 10.1186/s13075-015-0781-4

Flynn, T. J., Cadzow, M., Dalbeth, N., Jones, P. B., Stamp, L. K., Harré Hindmarsh, J., Todd, A. S., Walker, R. J., Topless, R., & Merriman, T. R. (2015). Positive association of tomato consumption with serum urate: Support for tomato consumption as an anecdotal trigger of gout flares. BMC Musculoskeletal Disorders, 16, 196. doi: 10.1186/s12891-015-0661-8

Kienhorst, L. B. E., van Lochem, E., Kievit, W., Dalbeth, N., Merriman, M. E., Phipps-Green, A., … Stamp, L. K., … Merriman, T. R., … Radstake, T. R. D. J. (2015). Gout is a chronic inflammatory disease in which high levels of interleukin 8 (CXCL8), myeloid-related protein 8/myeloid-related protein14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease. Arthritis & Rheumatology, 67(12), 3303-3313. doi: 10.1002/art.39318

Roberts, R. L., Wallace, M. C., Harrison, A., Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2015). A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout. Pharmacogenetics & Genomics, 25(8), 412-415. doi: 10.1097/fpc.0000000000000147

Roberts, R. L., & Stamp, L. K. (2015). Pharmacogenetic considerations in the treatment of gout. Pharmacogenomics, 16(6), 619-629. doi: 10.2217/pgs.15.16

Murphy, R., Thornley, S., de Zoysa, J., Stamp, L. K., Dalbeth, N., & Merriman, T. R. (2015). Sugar sweetened beverage consumption among adults with gout or type 2 diabetes. PLoS ONE, 10(5), e0125543. doi: 10.1371/journal.pone.0125543

Johnston, M. E., Treharne, G. J., Chapman, P. T., & Stamp, L. K. (2015). Patient information about gout: An international review of existing educational resources. Journal of Rheumatology, 42(6), 975-978. doi: 10.3899/jrheum.141442

Huffman, J. E., Albrecht, E., Teumer, A., Mangino, M., Kapur, K., Johnson, T., … Phipps-Green, A., … Stamp, L., & . . . (2015). Modulation of genetic associations with serum urate levels by body-mass-index in humans. PLoS ONE, 10(3), e0119752. doi: 10.1371/journal.pone.0119752

Taylor, W. J., Fransen, J., Jansen, T. L., Dalbeth, N., Schumacher, H. R., Brown, M., … Stamp, L. K., … Neogi, T. (2015). Study for updated gout classification criteria: Identification of features to classify gout. Arthritis Care & Research, 67(9), 1304-1315. doi: 10.1002/acr.22585

Aimer, P., Stamp, L., Stebbings, S., Valentino, N., Cameron, V., & Treharne, G. J. (2015). Identifying barriers to smoking cessation in rheumatoid arthritis. Arthritis Care & Research, 67(5), 607-615. doi: 10.1002/acr.22503

Aati, O., Taylor, W. J., Siegert, R. J., Horne, A., House, M. E., Tan, P., … Stamp, L. K., & Dalbeth, N. (2015). Development of a patient-reported outcome measure of tophus burden: The Tophus Impact Questionnaire (TIQ-20). Annals of the Rheumatic Diseases, 74, 2144-2150. doi: 10.1136/annrheumdis-2014-205671

Journal - Research Other

Hudson, B., Williman, J. A., Stamp, L. K., Alchin, J. S., Hooper, G. J., Mangin, D., Thompson, B. F., & Toop, L. (2015). Nortriptyline in knee osteoarthritis (NortIKA Study): Study protocol for a randomised controlled trial. Trials, 16, 448. doi: 10.1186/s13063-015-0961-1

Dalbeth, N., Winnard, D., Gow, P. J., Boswell, D. R., Te Karu, L., Lindsay, K., … Stamp, L. K. (2015). Urate testing in gout: Why, when and how. New Zealand Medical Journal, 128(1420). Retrieved from https://www.nzma.org.nz/journal

Dalbeth, N., & Stamp, L. K. (2015). Gout: Why compare the effectiveness of suboptimal gout management? Nature Reviews Rheumatology, 11, 506-507. doi: 10.1038/nrrheum.2015.94

Dalbeth, N., House, M. E., Aati, O., Tan, P., Franklin, C., Horne, A., … Stamp, L. K., … McQueen, F. M. (2015). Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: A dual energy CT study [Concise report]. Annals of the Rheumatic Diseases, 74, 908-911. doi: 10.1136/annrheumdis-2014-206397

Conference Contribution - Published proceedings: Abstract

Houlder, E., Millier, M., Highton, J., Stamp, L. K., & Hessian, P. (2015). Expression of the genes facilitating methotrexate action within rheumatoid subcutaneous nodules. Arthritis & Rheumatology, 67, 1613. doi: 10.1002/art.39448

Fatima, T., Merriman, T. R., Dalbeth, N., & Stamp, L. K. (2015). Association of melanocortin receptor polymorphisms with gout in New Zealand Pacific, Māori and European populations. In C. Matthewson, M. Taumoepeau, I. Iati, M. Inder, C. Pau & R. Richards (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices XII. (pp. 17). Dunedin, New Zealand: Pacific Islands Centre, University of Otago. [Abstract]

Treharne, G., Gath, M., Stebbings, S., Aimer, P., Kirby, S., & Stamp, L. K. (2015). Can a country go smoke-free? Exploring the views of smokers and ex-smokers with rheumatoid arthritis. Proceedings of the International Society of Critical Health Psychology (ISCHP) 9th Biennial Conference. (pp. 19). Retrieved from http://www.ischp2015.co.za/

Wrigley, R., Flynn, T., Stamp, L., Dalbeth, N., & Merriman, T. R. (2015). Fruit consumption is not positively associated with serum urate or risk of prevalent gout. New Zealand Medical Journal, 128(1421). Retrieved from https://www.nzma.org.nz/journal

Kannangara, D., Day, R., Williams, K., Phipps-Green, A., Dalbeth, N., Stamp, L., & Merriman, T. (2015). The urate transporter ABCG2 and the fractional renal clearance of urate (FCU): Changing the way we think about hyperuricaemia. Internal Medicine Journal, 45(Suppl. 2), (pp. 14). doi: 10.1111/imj.12752

Kennedy, N., Chambers, S., Nolan, I., Gallagher, K., Browne, M., & Stamp, L. (2015). Native joint septic arthritis in a New Zealand population. Internal Medicine Journal, 45(Suppl. 2), (pp. 19). doi: 10.1111/imj.12752

Kannangara, D., Graham, G., Wright, D., Barclay, M., Stamp, L., Williams, K., & Day, R. (2015). Treating gout patients with allopurinol: A concentration- or dose-response approach? Internal Medicine Journal, 45(Suppl. 2), (pp. 13). doi: 10.1111/imj.12752

Wright, D. F. B., Duffull, S. B., Merriman, T. R., Barclay, M. L., & Stamp, L. K. (2015). Allopurinol dosing in patients with renal impairment. Proceedings of the Twenty-Fourth Annual Meeting of the Population Approach Group in Europe (PAGE). 3338. Retrieved from http://www.page-meeting.org/

Conference Contribution - Poster Presentation (not in published proceedings)

Rasheed, H., Phipps-Green, A. J., Topless, R., Smith, M., Hill, C., Lester, S., … van Rij, A., Jones, G. T., McCormick, S. P., Harrison, A. A., Stamp, L. K., … Merriman, T. R. (2015, August-September). Replication of association of the apolipoprotein A1-C3-A4 cluster with gout risk: Evidence for a causal role in gout. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Fatima, T., Altaf, S., Phipps-Green, A., Topless, R., Flynn, T. J., Stamp, L. K., … Merriman, T. R. (2015, August-September). Association analysis of the Beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Eason, C. T., Adams, S. L., McNabb, P., Romanazzi, D., Puddick, J., King, N., … Hessian, P. A., Stamp, L. K., & Packer, M. A. (2015, June-July). Synergies between production, protection and added value: New mussel research and HVN. Verbal presentation at the New Zealand Institute of Food Science & Technology (NZIFST) 50^th Anniversary Conference, Palmerston North, New Zealand.

Wright, D. F. B., Duffull, S. B., Merriman, T. R., Dalbeth, N., Barclay, M. L., & Stamp, L. K. (2015, September). Predicting allopurinol response in patients with renal impairment. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Stamp, L., Frampton, C., Hooper, G., Rothwell, A., & Chapman, P. (2015, September). Joint replacement surgery in inflammatory arthritis: Changes over time. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Stamp, L., Hamilton, S., Chapman, P., & Judd, A. (2015, September). Audit of gout management in primary care. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Kennedy, N., Stamp, L., Chambers, S., Nolan, I., Werno, A., & Brown, M. (2015, September). Native joint septic arthritis: Epidemiology, clinical features and microbiological causes in a New Zealand population. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

2014

Journal - Research Article

Rasheed, H., Hsu, A., Dalbeth, N., Stamp, L. K., McCormick, S., & Merriman, T. R. (2014). The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout. Arthritis Research & Therapy, 16(6), 495.

Stamp, L. K., & Chapman, P. T. (2014). Urate-lowering therapy: Current options and future prospects for elderly patients with gout. Drugs & Aging, 31(11), 777-786. doi: 10.1007/s40266-014-0214-0

Pan, S., Stamp, L. K., Duffull, S. B., Barclay, M. L., Dalrymple, J. M., Drake, J., Zhang, M., & Korell, J. (2014). Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis. Clinical Pharmacokinetics, 53(12), 1161-1170. doi: 10.1007/s40262-014-0179-5

Knake, C., Stamp, L., & Bahn, A. (2014). Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment. Biochemical & Biophysical Research Communications, 452, 157-162. doi: 10.1016/j.bbrc.2014.08.068

Stamp, L. K., Turner, R., Khalilova, I. S., Zhang, M., Drake, J., Forbes, L. V., & Kettle, A. J. (2014). Myeloperoxidase and oxidation of uric acid in gout: Implications for the clinical consequences of hyperuricaemia. Rheumatology, 53(11), 1958-1965. doi: 10.1093/rheumatology/keu218

Stamp, L. K., Merriman, T. R., Barclay, M. L., Singh, J. A., Roberts, R. L., Wright, D. F. B., & Dalbeth, N. (2014). Impaired response or insufficient dosage? Examining the potential causes of ”inadequate response” to allopurinol in the treatment of gout. Seminars in Arthritis & Rheumatism, 44(2), 170-174. doi: 10.1016/j.semarthrit.2014.05.007

Stamp, L. K., & Barclay, M. (2014). Therapeutic drug monitoring in rheumatic diseases: Utile or futile? Rheumatology, 53(6), 988-997. doi: 10.1093/rheumatology/ket355

Roberts, R. L., Wallace, M. C., Wright, D. F. B., Cadzow, M., Dalbeth, N., Jones, P. B., Stamp, L. K., Harrison, A. A., Black, M. A., & Merriman, T. R. (2014). Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone. Joint Bone Spine, 81(2), 160-163. doi: 10.1016/j.jbspin.2013.07.006

Batt, C., Phipps-Green, A. J., Black, M. A., Cadzow, M., Merriman, M. E., Topless, R., … Harrison, A., Highton, J., … Stamp, L., … Merriman, T. R. (2014). Sugar-sweetened beverage consumption: A risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Annals of the Rheumatic Diseases, 73(12), 2101-2106. doi: 10.1136/annrheumdis-2013-203600

Korell, J., Duffull, S. B., Dalrymple, J. M., Drake, J., Zhang, M., Barclay, M. L., & Stamp, L. K. (2014). Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types. British Journal of Clinical Pharmacology, 77(3), 493-497. doi: 10.1111/bcp.12209

Journal - Research Other

Stamp, L., & Dalbeth, N. (2014). Screening for hyperuricaemia and gout: A perspective and research agenda. Nature Reviews Rheumatology, 10, 752-756. doi: 10.1038/nrrheum.2014.139

Dalbeth, N., & Stamp, L. (2014). Hyperuricaemia and gout: Time for a new staging system? Annals of the Rheumatic Diseases, 73(9), 1598-1600. doi: 10.1136/annrheumdis-2014-205304

Sies, C. W., Florkowski, C. M., Frampton, C. M. A., O'Donnell, J. L., Chapman, P. T., & Stamp, L. K. (2014). Comparison of two plasma urate assays in patients receiving vitamin C supplementation [Chemical pathology]. Pathology, 46(4), 333-335. doi: 10.1097/pat.0000000000000095

Roberts, R. L., Wallace, M. C., Drake, J. M., & Stamp, L. K. (2014). Identification of a novel thiopurine S-methyltransferase allele (TPMT*37) [Short communication]. Pharmacogenetics & Genomics, 24(6), 320-323. doi: 10.1097/fpc.0000000000000049

Journal - Professional & Other Non-Research Articles

Roberts, R. L., Wallace, M. C., Wright, D. F. B., Cadzow, M., Dalbeth, N., Jones, P. B., Stamp, L. K., Harrison, A. A., Black, M. A., & Merriman, T. R. (2014). Fréquence des polymorphismes du CYP2C9 chez les Polynésiens et pertinence potentielle concernant le traitement de la goutte par benzbromarone. Revue du Rhumatisme, 81(2), 159-163. doi: 10.1016/j.rhum.2013.08.005

Conference Contribution - Published proceedings: Abstract

Pan, S., Korell, J., Stamp, L., & Duffull, S. (2014). Simplification of a pharmacokinetic model for red blood cell methotrexate disposition. Proceedings of the 16th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/dunedin-2014/

Wright, D. F. B., Merriman, T. R., Duffull, S. B., Barclay, M. L., & Stamp, L. K. (2014). The relationship between fractional urate clearance and renal transporter genotype in patients with gout. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) Joint Scientific Meeting. (pp. 47). Retrieved from http://www.asceptasm.com/

Kannangara, D. R. W., Williams, K. M., Graham, G. G., Day, R. O., Phipps-Green, A. J., Dalbeth, N., Stamp, L. K., & Merriman, T. R. (2014). Insights into the pathophysiology of hyperuricaemia. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) Joint Scientific Meeting. (pp. 27). Retrieved from http://www.asceptasm.com/

Barclay, M. L., Helms, E., Hock, B., Schultz, M., & Stamp, L. K. (2014). Trough concentrations of infliximab and adalimumab, and anti-drug antibodies, correlate with drug response in inflammatory bowel disease. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) Joint Scientific Meeting. (pp. 25). Retrieved from http://www.asceptasm.com/

Rasheed, H., Hsu, A., Dalbeth, N., Stamp, L. K., McCormick, S., & Merriman, T. R. (2014). Association analysis of apolipoprotein B and very low-density lipoprotein with hyperuricemia and gout. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S1295-S1296). doi: 10.1002/art.38914

Rasheed, H., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., … Stamp, L. K., … McKinney, C., & Merriman, T. R. (2014). Association of the toll-like receptor 4 (TLR4) gene with gout. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S1294-S1295). doi: 10.1002/art.38914

Merriman, T. R., Merriman, M. E., Topless, R., Altaf, S., Montgomery, G., Franklin, C., Jones, G. T., van Rij, A. M., … Stamp, L. K., … Phipps-Green, A. (2014). Twenty-eight loci that influence serum urate levels: Analysis of association with gout. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S1293). doi: 10.1002/art.38914

Stamp, L. K., Chapman, P. T., Watts, R. A., Frampton, C., & O'Donnell, J. L. (2014). Environmental risk factors for granulomatous polyangiitis (GPA): Southern hemisphere similar to northern hemisphere. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S772). doi: 10.1002/art.38914

McGettigan, B., O'Donnell, J. L., Chapman, P. T., Frampton, C., & Stamp, L. K. (2014). An analysis of the incidence and characteristics of ANCA positive vasculitis before and after the Christchurch Earthquake. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S771-S772). doi: 10.1002/art.38914

Stamp, L. K., Chapman, P. T., O'Donnell, J. L., Khalilova, I., Turner, R., & Kettle, A. (2014). Oxidative stress from use of allopurinol: Is there a reason for patients with gout to take vitamin C? Arthritis & Rheumatology, 66(10, Suppl.), (pp. S532-S533). doi: 10.1002/art.38914

Dalbeth, N., House, M., Aati, O., Tan, P., Franklin, C., Horne, A., … Stamp, L. K., … McQueen, F. M. (2014). Extent of urate deposition in asymptomatic hyperuricemia and symptomatic gout. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S365). doi: 10.1002/art.38914

Merriman, T. R., Dalbeth, N., Jones, P. B. B., Stamp, L. K., Cadzow, M., Topless, R., & Flynn, T. (2014). Positive association between tomato consumption and serum urate: Investigating an anecdotal trigger of gout flares. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S70). doi: 10.1002/art.38914

Aimer, P., Treharne, G., Stebbings, S., Frampton, C., Cameron, V., Kirby, S., & Stamp, L. K. (2014). A pilot randomized controlled trial of a tailored smoking cessation intervention for rheumatoid arthritis patients. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S1035). doi: 10.1002/art.38914

Johnston, M., Treharne, G., Chapman, P. T., & Stamp, L. K. (2014). Self-management education for patients with gout: A review of existing resources. Arthritis & Rheumatology, 66(10, Suppl.), (pp. S72-S73). doi: 10.1002/art.38914

Flynn, T. J., Cadzow, M., Dalbeth, N., Jones, P. B., Stamp, L. K., Topless, R., & Merriman, T. R. (2014). New Zealanders with gout: Investigating anecdotal reports of tomatoes as a dietary gout trigger. In C. Matthewson, M. Taumoepeau & I. Iati (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices XI. (pp. 17). Dunedin, New Zealand: Pacific Islands Centre, University of Otago. [Abstract]

Harper, J. L., McLaughlin, R. M., Grainger, R., He, S., Harrison, A. A., Martin, W.-J., Kettle, T., & Stamp, L. K. (2014). Soluble urate: An endogenous driver of immune moderation. Proceedings of the Medical Sciences Congress (MedSci). (pp. 13). Retrieved from http://www.physoc.org.nz/meetings/archive/medsci-2014-abstracts

Conference Contribution - Verbal presentation and other Conference outputs

Stamp, L. K. (2014, November). Pharmacogenetics of gout. Verbal presentation at the 10th Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Barclay, M. L., Helms, E., Hock, B., Stamp, L. K., & Schultz, M. (2014, November). Infliximab and adalimumab trough concentrations and anti-drug antibodies correlate with response in inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.

Stamp, L. (2014, August). Pharmacology and therapeutics in RA. Invited presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin, New Zealand.

Johnston, M., Stamp, L., & Treharne, G. (2014, August). Self-management education for patients with gout: A review of existing resources. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin, New Zealand.

Aimer, P., Stamp, L., Stebbings, S., Valentino, N., Kirby, S., Cameron, V., & Treharne, G. J. (2014, August). Planning a tailored smoking cessation intervention for rheumatoid arthritis patients. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin, New Zealand.

Rasheed, H., Hsu, A., Dalbeth, N., Stamp, L., McCormick, S., & Merriman, T. (2014, August). Association analysis of apolipoprotein B and very low-density lipoprotein with gout in the presence of hyperuricemia. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin, New Zealand.

Merriman, T., Altaf, S., Montgomery, G., Franklin, C., Jones, G., van Rij, A., … Stamp, L. (2014, August). Twenty-eight loci that influence serum urate levels: Analysis of association with gout. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin, New Zealand.

Flynn, T., Cadzow, M., Dalbeth, N., Jones, P., Stamp, L., Topless, R., & Merriman, T. (2014, August). Positive association between tomato consumption and serum urate: Investigating an anecdotal trigger of gout flares. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin, New Zealand.

Stamp, L., Chapman, P., Frampton, C., & O'Donnell, J. (2014, August). Environmental risk factors for granulomatous polyangiitis. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Dunedin, New Zealand.

Stamp, L. (2014, August). Predicting response to allopurinol. Verbal presentation at the University of Otago Arthritis Research Theme Meeting, Dunedin, New Zealand.

Fatima, T., Jones, G. T., Phipps-Green, A., Stamp, L., Dalbeth, N., & Merriman, T. R. (2014, August). Association analysis of inflammatory markers with gout and hyperuricaemia in New Zealand case-control sample sets: Interleukins 15 and 2. Verbal presentation at the University of Otago Arthritis Research Theme Meeting, Dunedin, New Zealand.

Rasheed, H., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., … Stamp, L. K., … Merriman, T. R. (2014, August). Association of the toll-like receptor 4 (TLR4) gene with gout. Verbal presentation at the University of Otago Arthritis Research Theme Meeting, Dunedin, New Zealand.

2013

Journal - Research Article

Prowse, R. L., Dalbeth, N., Kavanaugh, A., Adebajo, A. O., Gaffo, A. L., Terkeltaub, R., … Stamp, L. K., … Chapman, P., … Grainger, R., … Taylor, W. J. (2013). A Delphi exercise to identify characteristic features of gout: Opinions from patients and physicians, the first stage in developing new classification criteria. Journal of Rheumatology, 40(4), 498-505. doi: 10.3899/jrheum.121037

Flynn, T. J., Phipps-Green, A., Hollis-Moffatt, J. E., Merriman, M. E., Topless, R., Montgomery, G., … Stamp, L. K., … Merriman, T. R. (2013). Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis Research & Therapy, 15, R220. doi: 10.1186/ar4417

Stamp, L. K. (2013). Safety profile of anti-gout agents: An update. Current Opinion in Rheumatology, 26(2), 162-168. doi: 10.1097/bor.0000000000000031

Rasheed, H., Phipps-Green, A., Topless, R., Hollis-Moffatt, J. E., Harré Hindmarsh, J., Franklin, C., … Stamp, L. K., & Merriman, T. R. (2013). Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption. Arthritis Research & Therapy, 15, R177. doi: 10.1186/ar4366

Roberts, R. L., Wallace, M. C., Jones, G. T., van Rij, A. M., Merriman, T. R., Harrison, A., … Stamp, L. K., … Highton, J., & Stebbings, S. M. (2013). Prevalence of HLA-B27 in the New Zealand population: Effect of age and ethnicity. Arthritis Research & Therapy, 15, R158. doi: 10.1186/ar4341

Stamp, L. K., Hazlett, J., Highton, J., & Hessian, P. A. (2013). Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue. Journal of Rheumatology, 40(9), 1519-1522. doi: 10.3899/jrheum.130066

Stamp, L. K., Wells, J. E., Pitama, S., Faatoese, A., Doughty, R. N., Whalley, G., Richards, A. M., & Cameron, V. A. (2013). Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities. Internal Medicine Journal, 43(6), 678-684. doi: 10.1111/imj.12062

Stamp, L. K., O'Donnell, J. L., Frampton, C., Drake, J. M., Zhang, M., & Chapman, P. T. (2013). Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: A pilot randomized controlled trial. Arthritis & Rheumatism, 65(6), 1636-1642. doi: 10.1002/art.37925

Wright, D. F. B., Stamp, L. K., Merriman, T. R., Barclay, M. L., Duffull, S. B., & Holford, N. H. G. (2013). The population pharmacokinetics of allopurinol and oxypurinol in patients with gout. European Journal of Clinical Pharmacology, 69(7), 1411-1421. doi: 10.1007/s00228-013-1478-8

Korell, J., Stamp, L. K., Barclay, M. L., Dalrymple, J. M., Drake, J., Zhang, M., & Duffull, S. B. (2013). A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells. Clinical Pharmacokinetics, 52(6), 475-485. doi: 10.1007/s40262-013-0052-y

Khan, E. A. R., Stamp, L. K., O'Donnell, J. L., & Chapman, P. T. (2013). Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999–2008. International Journal of Rheumatic Diseases, 16(1), 19-23. doi: 10.1111/1756-185x.12008

Stamp, L. K., & Chapman, P. T. (2013). Gout and its comorbidities: Implications for therapy. Rheumatology, 52(1), 34-44. doi: 10.1093/rheumatology/kes211

Journal - Research Other

Gow, P., Stamp, L., Merriman, T., Stuart, R., Winnard, D., Lindsay, K., for the New Zealand Rheumatology Association, and the Māori Gout Action Group. (2013). New urate-lowering therapies in Aotearoa New Zealand: A response to Dr Lance Gravatt's letter on benzbromarone hepatotoxicity. New Zealand Medical Journal, 126(1382). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Pan, S., Korell, J., Stamp, L., & Duffull, S. (2013). Relating intracellular methotrexate polyglutamate concentrations in red blood cells with clinical response in rheumatoid arthritis. Proceedings of the 15th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/brisbane-2013/

Stamp, L. K., Knake, C., & Bahn, A. (2013). A clinically significant interaction between furosemide and allopurinol: Potential implications for clinical practice. Arthritis & Rheumatism, 65(10, Suppl.), (pp. S496). doi: 10.1002/art.38216

Merriman, T. R., Phipps-Green, A., Hollis-Moffatt, J. E., Merriman, M. E., Topless, R., Montgomery, G., … Stamp, L. K., … Flynn, T. (2013). Association analysis of the organic anion transporter 4 and urate transporter 1 locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis & Rheumatism, 65(10, Suppl.), (pp. S63-S64). doi: 10.1002/art.38216

Coman-Wright, N., Chapman, P. T., O'Donnell, J. L., & Stamp, L. K. (2013). Allopurinol dose above creatinine clearance based dose is safe and effective in gout: Compliance, efficacy and safety at 2 and 3 Years. Arthritis & Rheumatism, 65(10, Suppl.), (pp. S507). doi: 10.1002/art.38216

Batt, C., Phipps-Green, A. J., Black, M. A., Cadzow, M., Merriman, M. E., Topless, R., … Harrison, A., Highton, J., … Stamp, L., … Merriman, T. R. (2013). Sugary drinks and the risk of gout: Evidence for SLC2A9 gene interaction. New Zealand Medical Journal, 126(1384). Retrieved from http://www.nzma.org.nz/journal

Aimer, P., Treharne, G., Stebbings, S., Valentino, N., Cameron, V., & Stamp, L. (2013). Smoking cessation and rheumatoid arthritis. Proceedings of the International Society of Critical Health Psychology (ISCHP) 8th Biennial Conference. (pp. 73). Retrieved from http://www.bradford.ac.uk/ssis/ischp/

Merriman, T., Phipps-Green, A., Black, M., Cadzow, M., Merriman, M., Topless, R., … Harrison, A., Highton, J., … Stamp, L., … Batt, C. (2013). Sugar-sweetened beverage consumption: A risk factor for prevalent gout that interacts with SLC2A9 genotype in a non-additive fashion. Internal Medicine Journal, 43(Suppl. 2), (pp. 2). doi: 10.1111/imj.12139

Conference Contribution - Poster Presentation (not in published proceedings)

Flynn, T. J., Phipps-Green, A., Hollis-Moffatt, J. E., Merriman, M. E., Topless, R., Montgomery, G., … Stamp, L. K., … Merriman, T. R. (2013, September). Association analysis of two urate transporters, SLC22A11 (OAT4) and SLC22A12 (URAT1), with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.

Rasheed, H., Topless, R., Phipps-Green, M., Hollis-Moffatt, J. E., Harré Hindmarsh, J., Dalbeth, N., … Stamp, L. K., & Merriman, T. R. (2013, September). Association of the LRP2 gene with gout and non-additive interaction with alcohol consumption. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.

Batt, C., Stamp, L., & Gearry, R. (2013, September). Prevalence of fructose malabsorption in patients with gout. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Stamp, L. (2013, December). Uric acid the master regulator. Verbal presentation at the University of Otago Triple Theme Research Meeting: The Kidney in Health and Disease, Gut Health Network, Arthritis Research, Dunedin, New Zealand.

Kettle, A. J., Turner, R., Stamp, L., Wu, Y., Li, L., Tang, W. H. W., … Akerstrom, B. (2013, August). Oxidation of uric acid during inflammation and cardiovascular disease. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Pan, S., Korell, J., Stamp, L., & Duffull, S. (2013, August). Assessment of the activity of red blood cell methotrexate polyglutamates. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Other Research Output

Stamp, L. (2013, April). Gout: A disease of New Zealand, University of Otago Christchurch Health Lecture Series. Christchurch, New Zealand. [Public Seminar].

2012

Chapter in Book - Research

Dalbeth, N., & Stamp, L. K. (2012). Xanthine oxidase inhibitor treatment of hyperuricemia. In R. Terkeltaub (Ed.), Gout and other crystal arthropathies. (pp. 154-173). Philadelphia, PA: Saunders. doi: 10.1016/B978-1-4377-2864-4.10039-9

Journal - Research Article

Kazantseva, M. G., Highton, J., Stamp, L. K., & Hessian, P. A. (2012). Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis. Arthritis Research & Therapy, 14, R208. doi: 10.1186/ar4046

Stamp, L. K., Hazlett, J., Roberts, R. L., Frampton, C., Highton, J., & Hessian, P. A. (2012). Adenosine receptor expression in rheumatoid synovium: A basis for methotrexate action. Arthritis Research & Therapy, 14, R138. doi: 10.1186/ar3871

Raja, R., Chapman, P. T., O'Donnell, J. L., Ipenburg, J., Frampton, C., Hurst, M., & Stamp, L. K. (2012). Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association classification criteria for rheumatoid arthritis in an early arthritis cohort in New Zealand. Journal of Rheumatology, 39(11). doi: 10.3899/jrheum.120226

Stamp, L. K., Khalilova, I., Tarr, J. M., Senthilmohan, R., Turner, R., Haigh, R. C., … Kettle, A. J. (2012). Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology, 51(10), 1796-1803. doi: 10.1093/rheumatology/kes193

Stamp, L. K., Barclay, M. L., O'Donnell, J. L., Zhang, M., Drake, J., Frampton, C., & Chapman, P. T. (2012). Furosemide increases plasma oxypurinol without lowering serum urate—a complex drug interaction: Implications for clinical practice. Rheumatology, 51(9), 1670-1676. doi: 10.1093/rheumatology/kes091

Stamp, L. K., Taylor, W. J., Jones, P. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2012). Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol. Arthritis & Rheumatism, 64(8), 2529-2536. doi: 10.1002/art.34488

Hollis-Moffatt, J. E., Phipps-Green, A. J., Chapman, B., Jones, G. T., van Rij, A., Gow, P. J., Harrison, A. A., Highton, J., … Stamp, L. K., … Merriman, T. R. (2012). The renal urate transporter SLC17A1 locus: Confirmation of association with gout. Arthritis Research & Therapy, 14(2), R92. doi: 10.1186/ar3816

Stamp, L. K., & Chapman, P. T. (2012). Gout and organ transplantation. Current Rheumatology Reports, 14(2), 165-172. doi: 10.1007/s11926-012-0235-9

Hazlett, J., Stamp, L. K., Merriman, T., Highton, J., & Hessian, P. A. (2012). IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes & Immunity, 13, 282-287. doi: 10.1038/gene.2011.80

Chen-Xu, M., Topless, R., McKinney, C., Merriman, M. E., Phipps-Green, A., Dalbeth, N., … Harrison, A. A., Highton, J., … van Rij, A., Jones, G. T., … Stamp, L. K., … Merriman, T. R. (2012). Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets. Annals of the Rheumatic Diseases, 71(1), 155-157. doi: 10.1136/annrheumdis-2011-200591

Journal - Research Other

Hsu, A., Dalbeth, N., Gow, P., Harrison, A., Highton, J., Jones, P. B., Stamp, L. K., & Merriman, T. R. (2012). No evidence for association of Chr 9p21 variant rs1333049 with gout in New Zealand case-control sample sets. Rheumatology, 51, 1129-1130. doi: 10.1093/rheumatology/kes029

Stamp, L. K., Harrison, A., Frampton, C., & Corkill, M. M. (2012). Does a joint count calibration exercise make a difference? Implications for clinical trials and training. Journal of Rheumatology, 39(4), 877-878. doi: 10.3899/jrheum.111224

Turner, R., Stamp, L. K., & Kettle, A. J. (2012). Detection of allantoin in clinical samples using hydrophilic liquid chromatography with stable isotope dilution negative ion tandem mass spectrometry [Short communication]. Journal of Chromatography B, 891-892, 85-89. doi: 10.1016/j.jchromb.2012.02.009

Khan, A. R., Chapman, P. T., Stamp, L. K., Wells, J. E., & O'Donnell, J. L. (2012). Wegener's granulomatosis: Treatment and survival characteristics in a high-prevalence southern hemisphere region [Brief communication]. Internal Medicine Journal, 42(4), e23-e26. doi: 10.1111/j.1445-5994.2011.02700.x

Stamp, L. K., Ipenburg, J., Hurst, M., O'Donnell, J. L., Raja, R., Drake, J., & Chapman, P. T. (2012). The Christchurch earthquake: Providing a rheumatology service during a natural disaster [Brief report]. Clinical Rheumatology, 31(4), 723-725. doi: 10.1007/s10067-011-1913-0

Conference Contribution - Published proceedings: Abstract

Wright, D. F. B., Stamp, L. K., Merriman, T. R., Barclay, M. L., Duffull, S. B., & Holford, N. H. G. (2012). The population pharmacokinetics of allopurinol and oxypurinol. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Science Association (APSA) Joint Conference: Medication Safety. (pp. 55). Retrieved from http://www.ascept-apsa.com/

Merriman, T. R., Dalbeth, N., Gow, P. J., Harrison, A., Highton, J., Jones, P. B. B., Stamp, L. K., Cadzow, M., Merriman, M. E., Topless, R., Black, M. A., Phipps-Green, A., & Batt, C. M. (2012). Epistatic interaction between solute carrier 2A9 genotype and sugar-sweetened beverage consumption in the determination of gout risk. Arthritis & Rheumatism, 64(10, Suppl.), (pp. S696). doi: 10.1002/art.37735

Stamp, L. K., Khalilova, I., Zhang, M., Turner, R., & Kettle, A. (2012). Oxidation of urate to allantoin by myeloperoxidase in gout. Arthritis & Rheumatism, 64(10, Suppl.), (pp. S808). doi: 10.1002/art.37735

Stamp, L. K., Frampton, C., O'Donnell, J. L., Drake, J., & Chapman, P. T. (2012). Lack of effect of supplemental vitamin C on serum urate in patients with gout. Arthritis & Rheumatism, 64(10, Suppl.), (pp. S60-S61). doi: 10.1002/art.37735

Merriman, T. R., Dalbeth, N., Harrison, A., Highton, J., Stamp, L. K., Smith, M. D., … Merriman, M. E., Phipps-Green, A., Topless, R., Zamanpoor, M., & Wan Taib, W. R. (2012). The sex-determining region Y box 6 locus: Shared genetic susceptibility between rheumatoid arthritis and sychotic disorder. Arthritis & Rheumatism, 64(10, Suppl.), (pp. S505-S506). doi: 10.1002/art.37735

Stamp, L., Jones, P. B., Taylor, W., Dockerty, J., Drake, J., Frampton, C., & Dalbeth, N. (2012). Allopurinol hypersensitivy syndrome: a restrospective case-control study. New Zealand Medical Journal, 125(1366). Retrieved from http://www.nzma.org.nz/journal

Flynn, T., Hollis-Moffatt, J., Merriman, M., Phipps-Green, A., Topless, R., Dalbeth, N., … Harrison, A., Highton, J., … Stamp, L. (2012). Association analysis of urate transporters SLC22A11 (OAT4) and SLC22A12 (URAT1) with gout. Internal Medicine Journal, 42(Suppl. s1), (pp. 2). doi: 10.1111/j.1445-5994.2012.02759.x

Korell, J., Stamp, L. K., & Duffull, S. B. (2012). Pharmacokinetics of methotrexate in red blood cells. Proceedings of the Medical Sciences Congress (MedSci). (pp. 23). Retrieved from http://www.medscinz.co.nz/QRW2012%20MedSci%20Abstracts.pdf

Wright, D., Stamp, L., Duffull, S., & Holford, N. (2012). What is the best dosing regimen for allopurinol in patients with renal impairment? Proceedings of the 14th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/conference/melbourne-2012-14th-annual-scientific-meeting

Korell, J., Stamp, L., & Duffull, S. (2012). Pharmacokinetics of methotrexate in red blood cells. Proceedings of the 14th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/conference/melbourne-2012-14th-annual-scientific-meeting

Conference Contribution - Poster Presentation (not in published proceedings)

Knake, C., Stamp, L., & Bahn, A. (2012, September). Furosemide and allopurinol: An adverse drug interaction with clinical implications for treatment of gout in hypertensive patients. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.

Knake, C., Stamp, L., & Bahn, A. (2012, August). Furosemide and alloprinol: An adverse drug interaction with clinical implications for treatment of gout in hypertensive patients. Poster session presented at the Translational Nephrology Conference: From Mechanics to Therapeutics, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Stamp, L. (2012, September). Crossing the Great King St divide. Verbal presentation at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.

Walmsley, R., Coppell, K., Griffin, F., Barclay, M., & Stamp, L. (2012, June). Who are we (Part III). Panel discussion at the Inaugural GutHealth Network Workshop, Dunedin, New Zealand.

2011

Journal - Research Article

Hollis-Moffatt, J. E., Gow, P. J., Harrison, A. A., Highton, J., Jones, P. B. B., Stamp, L. K., … Merriman, T. R. (2011). The SLC2A9 nonsynonymous Arg265His variant and gout: Evidence for a population-specific effect on severity. Arthritis Research & Therapy, 13(3), R85. doi: 10.1186/ar3356

Stamp, L. K., & Roberts, R. L. (2011). Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases. Pharmacogenomics, 12(10), 1449-1463. doi: 10.2217/pgs.11.86

Stamp, L. K., Barclay, M. L., O'Donnell, J. L., Zhang, M., Drake, J., Frampton, C., & Chapman, P. T. (2011). Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis. Journal of Rheumatology, 38(12), 2540-2547. doi: 10.3899/jrheum.110481

Stamp, L. K., & Jordan, S. (2011). The challenges of gout management in the elderly. Drugs & Aging, 28(8), 591-603. doi: 10.2165/11592750-000000000-00000

Stamp, L. K., Barclay, M. L., O'Donnell, J. L., Zhang, M., Drake, J., Frampton, C., & Chapman, P. T. (2011). Relationship between serum urate and plasma oxypurinol in the management of gout: Determination of minimum plasma oxypurinol concentration to achieve a target serum urate level. Clinical Pharmacology & Therapeutics, 90(3), 392-398. doi: 10.1038/clpt.2011.113

Singh, J. A., Taylor, W. J., Simon, L. S., Khanna, P. P., Stamp, L. K., McQueen, F. M., … Schumacher, Jr, H. R. (2011). Patient-reported outcomes in chronic gout: A report from OMERACT 10. Journal of Rheumatology, 38(7), 1452-1457. doi: 10.3899/jrheum.110271

Dalbeth, N., McQueen, F. M., Singh, J. A., Macdonald, P. A., Edwards, N. L., Schumacher, Jr, H. R., … Stamp, L. K., … Taylor, W. J. (2011). Tophus measurement as an outcome measure for clinical trials of chronic gout: Progress and research priorities. Journal of Rheumatology, 38(7), 1458-1461. doi: 10.3899/jrheum.110272

Taylor, W. J., Singh, J. A., Saag, K. G., Dalbeth, N., Macdonald, P. A., Edwards, N. L., … Stamp, L. K., … Schumacher, Jr, H. R. (2011). Bringing it all together: A novel approach to the development of response criteria for chronic gout clinical trials. Journal of Rheumatology, 38(7), 1467-1470. doi: 10.3899/jrheum.110274

Stamp, L. K., Khanna, P. P., Dalbeth, N., Boers, M., Maksymowych, W. P., Schumacher, Jr, H. R., … Taylor, W. J. (2011). Serum urate in chronic gout: Will it be the first validated soluble biomarker in rheumatology? Journal of Rheumatology, 38(7), 1462-1466. doi: 10.3899/jrheum.110273

Stamp, L. K., & Chapman, P. (2011). Existing and emerging therapies for acute gout and long-term urate lowering. Current Rheumatology Reviews, 7(2), 141-151. doi: 10.2174/157339711795305031

Stamp, L. K., O'Donnell, J. L., Zhang, M., James, J., Frampton, C., Barclay, M. L., & Chapman, P. T. (2011). Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including in those with renal impairment. Arthritis & Rheumatism, 63(2), 412-421. doi: 10.1002/art.30119

Stamp, L. K., Zhu, X., Dalbeth, N., Jordan, S., Edwards, N. L., & Taylor, W. (2011). Serum urate as a soluble biomarker in chronic gout: Evidence that serum urate fulfills the OMERACT validation criteria for soluble biomarkers. Seminars in Arthritis & Rheumatism, 40(6), 483-500. doi: 10.1016/j.semarthrit.2010.09.003

Journal - Research Other

Phipps-Green, A., McKinney, C., Rossol, M., Merriman, M. E., Topless, R., Hollis-Moffatt, J. E., Wan Taib, W. R., … Harrison, A. A., Highton, J., … Stamp, L. K., … Merriman, T. R. (2011). Analysis of association of DNASE2 promoter variation with rheumatoid arthritis in European Caucasians [Letter]. Annals of the Rheumatic Diseases, 70(8), 1512-1514. doi: 10.1136/ard.2010.138727

Conference Contribution - Published proceedings: Abstract

Roberts, R. L., Wright, D. F. B., Dalbeth, N., Highton, J., Jones, P. B., Gow, P. J., Stamp, L. K., Harrison, A. A., & Merriman, T. R. (2011). The benzbromarone story: Is CYP2C9 genotype relevant to prescribing? Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and Carney Symposium: New Zealand Annual Scientific Meeting. 8.2. Retrieved from http://www.otago.ac.nz/asceptnz/docs/programme.pdf

Wright, D. F. B., Stamp, L. K., Roberts, R. L., Holford, N. H. G., & Duffull, S. B. (2011). A population pharmacokinetic model for allopurinol in gout patients. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and Carney Symposium: New Zealand Annual Scientific Meeting. 2.1. Retrieved from http://www.otago.ac.nz/asceptnz/docs/programme.pdf

Stamp, L. K., Taylor, W. J., Jones, P. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2011). Starting dose, but not maximum maintenance dose, is a risk factor for allopurinol hypersensitivity syndrome: A proposed nomogram for safe starting dose of allopurinol. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and Carney Symposium: New Zealand Annual Scientific Meeting. 1.3. Retrieved from http://www.otago.ac.nz/asceptnz/docs/programme.pdf

Stamp, L., Dockerty, J., Frampton, C., Robinson, P., Jones, P., Taylor, W., & Dalbeth, N. (2011). Allopurinol starting dose as a risk factor for allopurinol hypersensitivity syndrome in patients with gout. Annals of the Rheumatic Diseases, 70(Suppl. 3), (pp. 180). [Abstract]

Dalbeth, N., Glue, C., Stamp, L., Merriman, M., Topless, R., Gow, P., Harrison, A., Highton, J., … Merriman, T. (2011). Association between sugar-sweetened beverage consumption and gout in the New Zealand population. Annals of the Rheumatic Diseases, 70(Suppl. 3), (pp. 180). [Abstract]

Harrison, A., Hollis-Moffatt, J., Phipps-Green, A., Topless, R., Merriman, M., Dalbeth, N., … Highton, J., … Stamp, L., & Merriman, T. (2011). The SLC2A9 non-synonymous Arg265His variant and gout: Evidence for a population-specific effect on tophus formation. Annals of the Rheumatic Diseases, 70(Suppl. 3), (pp. 183). [Abstract]

Jones, P. B., Topless, R., Chen-Xu, M., Merriman, M., Dalbeth, N., Gow, P., Harrison, A., Highton, J., Stamp, L., & Merriman, T. (2011). No evidence for a strong role for common functional genetic variants in the inflammasome in determining the risk of gout. Annals of the Rheumatic Diseases, 70(Suppl. 3), (pp. 187). [Abstract]

Stamp, L., Hollis-Moffatt, J., Topless, R., Merriman, M., Dalbeth, N., Gow, P., Harrison, A., Highton, J., … Merriman, T. (2011). Confirmation of the association of SLC17A1 (NPT1) with gout in the New Zealand population. Annals of the Rheumatic Diseases, 70(Suppl. 3), (pp. 185). [Abstract]

Stamp, L. K., Taylor, W., Jones, P. B. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2011). Starting dose, but not maximum maintenance dose, is a risk factor for allopurinol hypersensitivity syndrome: A proposed nomogram for safe starting dosing of allopurinol. Arthritis & Rheumatism, 63(Suppl. 10), (pp. S1012). doi: 10.1002/art.33310

Stamp, L. K., Chapman, P. T., Barclay, M., Kremer, J. M., & Dervieux, T. (2011). Red blood cell folate polyglutamates are an important determinant of RA disease activity in patients on Methotrexate: Implications for folic acid supplementation. Arthritis & Rheumatism, 63(Suppl. 10), (pp. S961-S962). doi: 10.1002/art.33310

Merriman, T. R., Dalbeth, N., Stamp, L. K., Merriman, M. E., Topless, R., Gow, P. J., … Highton, J., … Glue, C. (2011). Association between sugar-sweetened beverage consumption and gout in the New Zealand population. Arthritis & Rheumatism, 63(Suppl. 10), (pp. S633-S634). doi: 10.1002/art.33310

Dervieux, T., Kremer, J. M., Roberts, R., & Stamp, L. K. (2011). Epistasis in folate mediated one carbon metabolism contributes to high disease activity in two cohorts of rheumatoid arthritis patients receiving long term Methotrexate therapy. Arthritis & Rheumatism, 63(Suppl. 10), (pp. S159). doi: 10.1002/art.33310

Merriman, T. R., Dalbeth, N., Hollis-Moffatt, J. E., Phipps-Green, A., Topless, R., Merriman, M. E., … Highton, J., … Stamp, L. K., & Altaf, S. (2011). Association with gout of PDZK1 variants that influence metabolic traits and serum urate levels. Arthritis & Rheumatism, 63(Suppl. 10), (pp. S78). doi: 10.1002/art.33310

Merriman, T. R., Phipps-Green, A., Cadzow, M., Topless, R., Merriman, M. E., Jones, G. T., van Rij, A. M., … Highton, J., … Stamp, L. K., & Hollis-Moffatt, J. E. (2011). Confirmation of association of urate transporter SLC17A1 (NPT1) with gout at a genome-wide level of significance. Arthritis & Rheumatism, 63(Suppl. 10), (pp. S78). doi: 10.1002/art.33310

Kazantseva, M. G., Stamp, L., Highton, J., & Hessian, P. (2011). Tobacco smoking and the HLA-DR shared epitope (SE) combine to influence matrix metalloproteinase (MMP)-9 expression in rheumatoid inflammation. Inflammation Research. 60(Suppl. 1), (pp. S176). doi: 10.1007/s00011-011-0341-6

Raja, R., Chapman, P., O'Donnell, J., Ipenburg, J., & Stamp, L. (2011). Comparison of the 2010 ACR/EULAR and the 1987 ACR classification criteria for RA in an early arthritis cohort in New Zealand. Internal Medicine Journal, 41(Suppl. 1), (pp. 19). doi: 10.1111/j.1445-5994.2010.02466.x

Harrison, A., Hollis-Moffatt, J., Phipps-Green, A., Topless, R., Merriman, M., Dalbeth, N., … Highton, J., … Stamp, L., & Merriman, T. (2011). The SLC2A9 non-synonymous Arg265His variant and gout: Evidence for a population-specific effect on tophus formation. Internal Medicine Journal. 41(Suppl. 1), (pp. 30). doi: 10.1111/j.1445-5994.2010.02466.x

Merriman, T., Stamp, L., Topless, R., Merriman, M., Dalbeth, N., Gow, P., Harrison, A., Highton, J., … Hollis-Moffatt, J. (2011). Confirmation of the association of SLC17A1 (NPT1) with gout in the New Zealand population. Internal Medicine Journal. 41(Suppl. 1), (pp. 29-30). doi: 10.1111/j.1445-5994.2010.02466.x

Merriman, T., Dalbeth, N., Stamp, L., Merriman, M., Topless, R., Gow, P., Harrison, A., Highton, J., … Glue, C. (2011). Association between sugar-sweetened beverage consumption and gout in the New Zealand population. Internal Medicine Journal. 41(Suppl. 1), (pp. 30). doi: 10.1111/j.1445-5994.2010.02466.x

Merriman, T., Dalbeth, N., Hollis-Moffatt, J., Phipps-Green, A., Topless, R., Merriman, M., … Harrison, A., Highton, J., … Stamp, L., & Altaf, S. (2011). Study of the PDZK1 variants influencing metabolic traits and uric acid levels in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Internal Medicine Journal. 41(Suppl. 1), (pp. 4). doi: 10.1111/j.1445-5994.2010.02464.x

Highton, J., Jones, P., Topless, R., Chen-Xu, M., Merriman, M., Dalbeth, N., … Harrison, A., Stamp, L., & Merriman, T. (2011). No evidence for a strong role for common functional genetic variants in the inflammasome in determining the risk of gout. Internal Medicine Journal. 41(Suppl. 1), (pp. 31). doi: 10.1111/j.1445-5994.2010.02466.x

Conference Contribution - Poster Presentation (not in published proceedings)

Hsu, A., Dalbeth, N., Gow, P., Harrison, A. A., Highton, J., Jones, P. B. B., Stamp, L. K., Merriman, T. R., & McCormick, S. P. (2011, September). Lipoprotein properties and type IV hyperlipoproteinemia (TIVH) in Māori and Pacific people with gout. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Kettle, A. J., Meotti, F., Turner, R., Mocatta, T., Jameson, G., Marshall, C., … Stamp, L. (2011, August). Interactions of myeloperoxidase and urate during inflammation. Verbal presentation at the Medical Sciences Congress (MedSci), Queenstown, New Zealand.

Roberts, R., Wright, D., Dalbeth, N., Highton, J., Jones, P., Gow, P., Stamp, L., Harrison, A., & Merriman, T. (2011, August). Frequency of CYP2C9 poor metaboliser genotypes in gout patients: Potential relevance of prospective genotyping to benzbromarone prescribing. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Auckland, New Zealand.

Roberts, R. L., Wright, D. F. B., Dalbeth, N., Highton, J., Jones, P. B., Gow, P. J., Stamp, L. K., Harrison, A. A., & Merriman, T. R. (2011, August). The benzbromarone story: Is CYP2C9 genotype relevant to prescribing? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and Carney Symposium: New Zealand Annual Scientific Meeting, Christchurch, New Zealand.

Stamp, L., Ipenburg, J., Hurst, M., Mohammed, R., O'Donnell, J., Drake, J., & Chapman, P. (2011, August). The Christchurch Earthquake: Providing a rheumatology service during a natural disaster. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Auckland, New Zealand.

Stamp, L., Taylor, W., Jones, P., Dockerty, J., Drake, J., Frampton, C., & Dalbeth, N. (2011, August). Starting dose, but not maximum maintenance dose, is a risk factor for allopurinol hypersensitivity syndrome: A proposed nomogram for safe starting dose of allopurinol. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Auckland, New Zealand.

Stamp, L., Drake, J., O'Donnell, J., Frampton, C., & Chapman, P. (2011, August). Effects of frusemide on serum urate and oxypurinol concentrations in patients with gout on allopurinol. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Auckland, New Zealand.

2010

Journal - Research Article

Rhodes, B., Merriman, M. E., Harrison, A., Nissen, M. J., Smith, M., Stamp, L., … Merriman, T. R., & Vyse, T. J. (2010). A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: Implications for clinical interpretation. PLoS Medicine, 7(9), e1000341. doi: 10.1371/journal.pmed.1000341

Wan Taib, W. R., Smyth, D. J., Merriman, M. E., Dalbeth, N., Gow, P. J., Harrison, A. A., Highton, J., … Stamp, L., … Merriman, T. R. (2010). The PTPN22 locus and rheumatoid arthritis: No evidence for an effect on risk independent of Arg620Trp. PLoS ONE, 5(10), e13544. doi: 10.1371/journal.pone.0013544

Phipps-Green, A. J., Hollis-Moffatt, J. E., Dalbeth, N., Merriman, M. E., Topless, R., Gow, P. J., Harrison, A. A., Highton, J., … Stamp, L. K., & Merriman, T. R. (2010). A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Human Molecular Genetics, 19(24), 4813-4819. doi: 10.1093/hmg/ddq412

Hollis-Moffatt, J. E., Chen-Xu, M., Topless, R., Dalbeth, N., Gow, P. J., Harrison, A. A., Highton, J., … van Rij, A., Jones, G. T., Stamp, L. K., & Merriman, T. R. (2010). Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: Confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance. Arthritis Research & Therapy, 12(3), R116. doi: 10.1186/ar3053

Avouac, J., Walker, U., Tyndall, A., Kahan, A., Matucci-Cerrinic, M., Allanore, Y., EUSTAR, including Stebbings, S., & Stamp, L. (2010). Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. Journal of Rheumatology, 37(7), 1488-1501. doi: 10.3899/jrheum.091165

McKinney, C., Fanciulli, M., Merriman, M. E., Phipps-Green, A., Alizadeh, B. Z., Koeleman, B. P. C., … Harrison, A. A., Highton, J., … Stamp, L. K., … Merriman, T. R. (2010). Association of variation in Fcγ receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Annals of the Rheumatic Diseases, 69, 1711-1716. doi: 10.1136/ard.2009.123588

Stamp, L. K., Chapman, P. T., O'Donnell, J. L., Zhang, M., James, J., Frampton, C., Barclay, M. L., Kennedy, M. A., & Roberts, R. L. (2010). Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Pharmacogenetics & Genomics, 20(6), 367-376. doi: 10.1097/FPC.0b013e3283398a71

Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Zhang, M., James, J., Frampton, C., & Barclay, M. L. (2010). Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis & Rheumatism, 62(2), 359-368. doi: 10.1002/art.27201

White, D. H. N., Chapman, P. T., O'Donnell, J. L., James, J., Frampton, C., & Stamp, L. K. (2010). Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long-term methotrexate for rheumatoid arthritis. Internal Medicine Journal, 40(8), 561-565. doi: 10.1111/j.1445-5994.2009.02059.x

Journal - Research Other

Roberts, R. L., Zhang, M., Marinaki, A. M., & Stamp, L. K. (2010). Does genetic variability in aldehyde oxidase and molybdenum cofactor sulfurase predict nonresponse to allopurinol? [Letter to the editors]. Alimentary Pharmacology & Therapeutics, 32(2), 310-311. doi: 10.1111/j.1365-2036.2010.04349.x

Stamp, L. K., O'Donnell, J. L., Barclay, M. L., Frampton, C., & Chapman, P. T. (2010). Response to comments [Letter to the editor]. Arthritis & Rheumatism, 62(8), 2560-2561. doi: 10.1002/art.27539

Parekh, K., Ching, D., Rahman, M. U., & Stamp, L. K. (2010). Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: A rare adverse event? (Case Report) [Letter to the editor]. Rheumatology, 49(9), 1785-1787. doi: 10.1093/rheumatology/keq101

Stamp, L. K., & Hurst, M. (2010). Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases? [Editorial]. Journal of Rheumatology, 37(4), 686-688. doi: 10.3899/jrheum.091426

Conference Contribution - Published proceedings: Abstract

Merriman, T. R., Merriman, M. E., Topless, R., Dalbeth, N., Gow, P., Harrison, A., Highton, J., … Stamp, L., Hollis-Moffatt, J. E., & Phipps-Green, M. (2010). A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. Internal Medicine Journal. 40(Suppl. 3), (pp. 20). doi: 10.1111/j.1445-5994.2010.02235_1.x

Merriman, T. R., Singh, D., Phipps-Green, M., Topless, R., Merriman, M. E., Dalbeth, N., … Harrison, A., Highton, J., … Stamp, L., … Wan Taib, W. (2010). The SOX6 gene: Evidence for shared genetic susceptibility between schizophrenia and rheumatoid arthritis in Caucasians. Internal Medicine Journal, 40(Suppl. 3), (pp. 20). doi: 10.1111/j.1445-5994.2010.02235_1.x

Kazantseva, M., Highton, J., Stamp, L. K., & Hessian, P. A. (2010). Dendritic cells and continued smoking in rheumatoid arthritis. Arthritis & Rheumatism, 62(Suppl. 10). doi: 10.1002/art.30166

Stamp, L. K., O'Donnell, J. L., Chapman, P., Zhang, M., James, J., Frampton, C., & Barclay, M. (2010). The effect on MTX polyglutamate concentration profile after changing from oral to subcutaneous methotrexate in rheumatoid arthritis. Arthritis & Rheumatism, 62(Suppl. 10). doi: 10.1002/art.30166

Stamp, L. K., Hazlett, J., Merriman, T., Highton, J., & Hessian, P. (2010). Serum concentrations of cytokines in the IL-23/IL-17A pathway may be modulated by polymorphisms in IL-23R. Arthritis & Rheumatism, 62(Suppl. 10). doi: 10.1002/art.30166

Taylor, W., Hamburger, S., Stamp, L. K., Horowitz, Z. D., & Dalbeth, N. (2010). Change in uric acid level is associated with change in patient reported outcomes in the context of a clinical trial for chronic gout. Arthritis & Rheumatism, 62(Suppl. 10). doi: 10.1002/art.30166

Stamp, L. K., Khalilova, I., & Kettle, T. (2010). Acute gout results in increased plasma myeloperoxidase: A potential mechanism for increased cardiovascular risk? Arthritis & Rheumatism, 62(Suppl. 10). doi: 10.1002/art.30166

Stamp, L. K., O'Donnell, J. L., Zhang, M., James, J., Frampton, C., Barclay, M. L., & Chapman, P. T. (2010). Using allopurinol above the dose based on creatinine clearance is effective and safe in chronic gout, including in those with renal impairment. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting and the 6th Annual Carney Pharmacogenomics Symposium. ASCEPT. Retrieved from http://www.ascept.org.nz/

Barclay, M. L., Stamp, L. K., O'Donnell, J. L., Zhang, M., Drake, J., Frampton, C., & Chapman, P. T. (2010). Effects of changing from oral to subcutaneous administration of methotrexate on RBC MTX polyglutamate concentrations and disease activity in patients with rheumatoid arthritis. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting and the 6th Annual Carney Pharmacogenomics Symposium. ASCEPT. Retrieved from http://www.ascept.org.nz/

Conference Contribution - Verbal presentation and other Conference outputs

Stamp, L. (2010, August). Acute joint problems. Verbal presentation at the George Abbott Symposium, Christchurch, New Zealand.

Stamp, L., Khalilova, I. S., Tarr, J. M., Senthilmohan, R., Haigh, R. C., Whiteman, M., … Kettle, A. J. (2010, November-December). Myeloperoxidase and oxidative stress in rheumatoid arthritis. Verbal presentation at the Society for Free Radical Research (SFRR) Australasia 19th Annual Conference, Akaroa, New Zealand.

Turner, R., Khalilova, I., Stamp, L., Meotti, F. C., Thomas, S., Rees, M. D., & Kettle, A. J. (2010, November-December). Interactions between urate and myeloperoxidase in gout. Verbal presentation at the Society for Free Radical Research (SFRR) Australasia 19th Annual Conference, Akaroa, New Zealand.

Khan, E., Stamp, L., O'Donnell, J., & Chapman, P. (2010, August). Cardiovascular risk in rheumatoid arthritis (RA) patients in North Canterbury 1999 - 2009. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Christchurch, New Zealand.

Stamp, L. (2010, August). Management of gout. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Christchurch, New Zealand.

Kettle, A., Meotti, F. C., Jameson, G. N. L., Stamp, L., Turner, R., Harwood, T., Stockwell, S. C., … Thomas, S. R. (2010, August). Linking myeloperoxidase and uric acid to cardiovascular disease. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Christchurch, New Zealand.

Khan, E., Chapman, P., Stamp, L., Wells, J. E., & O'Donnell, J. (2010, August). Wegner's Granulomatosis: Treatment and survival characteristics in Canterbury, New Zealand. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Christchurch, New Zealand.

Stamp, L. (2010, August). Maximising the efficacy of Methotrexate in RA. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Christchurch, New Zealand.

Stamp, L. (2010, July). Management of gout. Verbal presentation at the 14th Congress of Asia Pacific League of Associations for Rheumatology: Era of Biologics in the Asian Pacific Region, Hong Kong, China.

2009

Journal - Research Article

Hollis-Moffatt, J. E., Rowley, K. A., Phipps-Green, A. J., Merriman, M. E., Dalbeth, N., Gow, P., Harrison, A. A., Highton, J., … Stamp, L. K., … Merriman, T. R. (2009). The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets. Arthritis Research & Therapy, 11, R152. doi: 10.1186/ar2828

Stamp, L. K., Easson, A., Pettersson, L., Highton, J., & Hessian, P. A. (2009). Monocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis. Journal of Rheumatology, 36(11), 2403-2408. doi: 10.3899/jrheum.081304

Hollis-Moffatt, J. E., Xu, X., Dalbeth, N., Merriman, M. E., Topless, R., Waddell, C., … Harrison, A. A., Highton, J., … Stamp, L. K., & Merriman, T. R. (2009). Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis & Rheumatism, 60(11), 3485-3492. doi: 10.1002/art.24938

Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Zhang, M., Frampton, C., James, J., & Barclay, M. L. (2009). Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Arthritis & Rheumatism, 60(8), 2248-2256. doi: 10.1002/art.24653

Hollis-Moffatt, J. E., Merriman, M. E., Green, R. A., Rowley, K. A., Chapman, P. T., Dalbeth, N., … Harrison, A. A., Highton, J., … O'Donnell, J. L., Stamp, L. K., & Merriman, T. R. (2009). Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(8), 1340-1344. doi: 10.1136/ard.2008.090142

Journal - Research Other

Phipps-Green, A. J., Topless, R. K. G., Merriman, M. E., Dalbeth, N., Gow, P. J., Harrison, A. A., Highton, J., … Stamp, L. K., … Merriman, T. R. (2009). No evidence for association of the systemic lupus erythematosus-associated ITGAM variant, R77H, with rheumatoid arthritis in the Caucasian population [Letter to the editor]. Rheumatology, 48(12), 1614-1615. doi: 10.1093/rheumatology/kep254

Khan, E. A. R., Blake, J. W. H., & Stamp, L. K. (2009). Ticlopidine as a safe alternative for clopidogrel-associated arthritis [Letter to the editor]. Journal of Rheumatology, 36(4), 855-856. doi: 10.3899/jrheum.081131

Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Barclay, M. L., Kennedy, M. A., Frampton, C. M. A., & Roberts, R. L. (2009). Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to longterm therapy with methotrexate response in rheumatoid arthritis [Letter]. Annals of the Rheumatic Diseases, 68(1), 154-155. doi: 10.1136/ard.2008.089383

Conference Contribution - Published proceedings: Abstract

Merriman, T. R., Dalbeth, N., Phipps-Green, A., Merriman, M. E., Topless, R., Gow, P. J., Harrison, A. A., Highton, J., … Stamp, L. K., & Hollis-Moffatt, J. (2009). Association analysis of urate transporters, SLC2A9 and ABCG2, in gout in New Zealand Māori, Pacific Island and Caucasian case-control sample sets. Proceedings of the 5th New Zealand Molecular Mapping Workshop. (pp. 24). Retrieved from https://mapnet.agresearch.co.nz/mediawiki/images/2/29/MapNet_Workshop_BOOKLET_2009.pdf

Roberts, R. L., O'Donnell, J. L., Chapman, P. T., Zhang, M., James, J., Frampton, C., Kennedy, M. A., Barclay, M. L., & Stamp, L. K. (2009). Genetic polymorphisms in the folate pathway predict red blood cell folate concentrations but not methotrexate response in rheumatoid arthritis. Proceedings of the 5th Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.otago.ac.nz/christchurch/otago019049.pdf

Stamp, L., O'Donnell, J. L., Zhang, M., Frampton, C., Barclay, M., & Chapman, P. T. (2009). Increasing allopurinol dose above the recommended range is effective and safe in chronic gout, including in those with renal impairment: A pilot study. Arthritis & Rheumatism, 60(Suppl. 10), (pp. S729). doi: 10.1002/art.27423

Khan, A. R., Chapman, P. T., Stamp, L. K., Wells, J. E., & O'Donnell, J. (2009). Wegener's Granulomatosis: Treatment and survival characteristics in Canterbury, New Zealand. Internal Medicine Journal, 39(Suppl. 2), (pp. A57). doi: 10.1111/j.1445-5994.2009.01952.x

Kazantseva, M., Highton, J., Stamp, L. K., & Hessian, P. A. (2009). Smoking and aryl hydrocarbon receptor function in rheumatoid arthritis. Arthritis & Rheumatism, 60(Suppl. 10), (pp. S143-S144). doi: 10.1002/art.27423

Stamp, L., O'Donnell, J. L., Zhang, M., Frampton, C., Chapman, P. T., & Barclay, M. (2009). Relationship between serum urate and plasma oxypurinol: Is there a target plasma oxypurinol concentration to achieve serum urate ≤6mg/dL. Arthritis & Rheumatism, 60(Suppl. 10), (pp. S561). doi: 10.1002/art.27423

Merriman, T. R., Fanciulli, M., Merriman, M. E., Alizadeh, B. Z., Koeleman, B. P. C., Dalbeth, N., … Harrison, A. A., Highton, J., … Stamp, L. K., … McKinney, C. (2009). Association of low-affinity Fc gamma receptor 3B (FCGR3B) copy number variation with rheumatoid arthritis in Caucasian subjects. Internal Medicine Journal, 39(Suppl. 2), (pp. A39). doi: 10.1111/j.1445-5994.2009.01951_1.x

Merriman, T. R., Dalbeth, N., Phipps-Green, A., Merriman, M., Topless, R., Gow, P., Harrison, A., Highton, J., … Stamp, L., & Hollis-Moffatt, J. (2009). A strong role for the ABC-binding cassette G2 (ABCG2) gene in susceptibility to gout in New Zealand Western Polynesian, but not Eastern Polynesian (Mäori), cases and controls. Arthritis & Rheumatism, 60(Suppl. 10), (pp. S562-S563). doi: 10.1002/art.27423

Stamp, L., O'Donnell, J. L., Chapman, P. T., Zhang, M., Frampton, C., Barclay, M., Kennedy, M., & Roberts, R. (2009). Functional polymorphisms within the folate pathway predict red blood cell folate concentrations but are not associated with methotrexate response in RA. Arthritis & Rheumatism, 60(Suppl. 10), (pp. S150). doi: 10.1002/art.27423

Barclay, M. L., Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Zhang, M., Frampton, C., & James, J. (2009). Determinants of red blood cell methotrexate polyglutamate concentrations in patients with rheumatoid arthritis on long-term methotrexate. In D. Hay & S. Ngo (Eds.), Proceedings of the 43rd Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. 14. ASCEPT. [Abstract]

Wan Taib, W. R., Singh, D., Phipps-Green, A., Topless, R., Merriman, M., Dalbeth, N., … Harrison, A., Highton, J., … Stamp, L., … Merriman, T. (2009). Evidence for SOX6 that plays a role in rheumatoid arthritis and schizophrenia. Proceedings of the ComBio2009 Conference. [CD-ROM] [Abstract]

Merriman, T. R., Xu, X., Dalbeth, N., Merriman, M. E., McCallum, R., Waddell, C., … Harrison, A. A., Highton, J., … Stamp, L. K., & Hollis-Moffatt, J. E. (2009). A role for the urate transporter SLC2A9 gene in susceptability to gout in New Zealand Maori, Pacific Island and Caucasian case-control cohorts. Internal Medicine Journal, 39(Suppl. 2), (pp. A42). doi: 10.1111/j.1445-5994.2009.01951_1.x

Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Zhang, M., Frampton, C., James, J., & Barclay, M. L. (2009). Determinants of methotrexate red blood cell polyglutamates in patients with rheumatoid arthritis on long-term MTX. Internal Medicine Journal, 39(Suppl. 2), (pp. A43). doi: 10.1111/j.1445-5994.2009.01951_1.x

Stamp, L. K., O'Donnell, J. L., Zhang, M., Frampton, C., James, J., Barclay, M., & Chapman, P. T. (2009). Relationship between allopurinol dose, plasma oxypurinol concentration and serum urate. Internal Medicine Journal, 39(Suppl. 2), (pp. A43). doi: 10.1111/j.1445-5994.2009.01951_1.x

Hollis-Moffatt, J. E., Xu, X., Dalbeth, N., Merriman, M. E., McCallum, R., Phipps-Green, A. J., … Harrison, A. A., Highton, J., … Stamp, L. K., & Merriman, T. R. (2009). No evidence for association of the W64R variant of the andrenergic receptor beta 3 gene and the A222V variant of the methylenetetrahydrofolate reductase gene with gout in New Zealand Mäori, Pacific Island and Caucasian case-control cohorts. Internal Medicine Journal, 39(Suppl. 2), (pp. A42). doi: 10.1111/j.1445-5994.2009.01951_1.x

Conference Contribution - Verbal presentation and other Conference outputs

Merriman, T., Singh, D., Phipps-Green, A., Topless, R., Merriman, M., Dalbeth, N., … Harrison, A., Highton, J., … Stamp, L., … Taib, W. (2009, September). The SOX6 gene: Shared genetic susceptibility between schizophrenia and rheumatoid arthritis in Caucasians. Verbal presentation at the 16th New Zealand Schizophrenia Research Group Annual Research Conference, Dunedin, New Zealand.

Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Zhang, M., James, J., Frampton, C., & Barclay, M. L. (2009, September). Methotrexate polygutamate concentrations are not associated with disease control or toxicity in rheumatoid arthritis patients on long-term MTX. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting, Dunedin, New Zealand.

Roberts, R. L., O'Donnell, J. L., Chapman, P. T., Zhang, M., James, J., Frampton, C., Kennedy, M. A., Barclay, M. L., & Stamp, L. K. (2009, September). Genetic polymorphisms in the folate pathway are predictive of red blood cell folate concentrations but not methotrexate response in rheumatoid arthritis patients. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting, Dunedin, New Zealand.

Barclay, M. L., Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Zhang, M., Frampton, C., & James, J. (2009, September). Determinants of red blood cell methotrexate polyglutamate concentrations in patients with rheumatoid arthritis on long-term MTX. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting, Dunedin, New Zealand.

2008

Chapter in Book - Research

Stamp, L. (2008). Gout. In W. Horobin (Ed.), Diseases and disorders: Emphysema-Obesity (Vol. 2). (pp. 385). Tarrytown, NY: Marshall Cavendish.

Stamp, L. K., & Cleland, L. G. (2008). Rheumatoid arthritis. In L. U. Thompson & W. E. Ward (Eds.), Optimizing women's health through nutrition. (pp. 279-320). Boca Raton, FL: CRC Press.

Stamp, L. K., & Cleland, L. G. (2008). Foods and rheumatological diseases. In D. D. Metcalfe, H. A. Sampson & R. A. Simon (Eds.), Food allergy: Adverse reactions to foods and food additives. (4th ed.) (pp. 563-574). Malden, MA: Blackwell.

Journal - Research Article

Dalrymple, J. M., Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Zhang, M., & Barclay, M. L. (2008). Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis & Rheumatism, 58(11), 3299-3308.

Taylor, W. J., Schumacher, Jr, H. R., Baraf, H. S. B., Chapman, P., Stamp, L., Doherty, M., … Grainger, R., … Barskova, V. G. (2008). A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Annals of the Rheumatic Diseases, 67(6), 888-891. doi: 10.1136/ard.2007.079970

Taylor, W. J., Harrison, A. A., Highton, J., Chapman, P., Stamp, L., Dockerty, J., … Sew Hoy, M. (2008). Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement. Rheumatology, 47, 514-518. doi: 10.1093/rheumatology/ken004

Stamp, L. K., Easson, A., Lehnigk, U., Highton, J., & Hessian, P. A. (2008). Different T cell subsets in the nodule and synovial membrane: Absence of interleukin-17A in rheumatoid nodules. Arthritis & Rheumatism, 58(6), 1601-1608. doi: 10.1002/art.23455

McKinney, C., Merriman, M. E., Chapman, P. T., Gow, P. J., Harrison, A. A., Highton, J., … O'Donnell, J. L., … Stamp, L. K., Willis, J., … Merriman, T. R. (2008). Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Annals of the Rheumatic Diseases, 67, 409-413. doi: 10.1136/ard.2007.075028

Journal - Research Other

Stamp, L., Beckert, L., Lambie, N., MacDonald, S., & Meates-Dennis, M. (2008). Pulmonary haemorrhage in a 13-year-old girl: An unusual presentation of systemic lupus erythematosus. Journal of Paediatrics & Child Health, 44(12), 743-745. doi: 10.1111/j.1440-1754.2008.01418.x

Journal - Professional & Other Non-Research Articles

Stamp, L. (2008). [Review of the book Occupational and physical therapy for children with rheumatic diseases: A clinical handbook]. New Zealand Medical Journal, 121(1281). Retrieved from http://journal.nzma.org.nz/journal/121-1281/3257/content.pdf

Stamp, L. (2008). [Review of the book Osteoarthritis: National clinical guideline for care and management in adults]. New Zealand Medical Journal, 121(1275). Retrieved from http://journal.nzma.org.nz/journal/121-1275/3109/content.pdf

Conference Contribution - Published proceedings: Abstract

Wan Taib, W. R., McKinney, C., Highton, J., Dalbeth, N., Stamp, L., Gow, P. J., … Harrison, A. A., … Merriman, T. R. (2008). Evidence for a rheumatoid arthritis protective variant independent of R620W within the PTPN22 locus. Proceedings of the American Society of Human Genetics 58th Annual Meeting. (pp. 406). ASHG. Retrieved from http://www.ashg.org/2008meeting/pdf/abstractbook1.pdf

Stamp, L. K., Easson, A., Highton, J., & Hessian, P. A. (2008). Does the absence of IL-17A in rhuematoid nodules give insights into mechanisms of autoimmunity in RA? Internal Medicine Journal, 38(Suppl. 2), (pp. A12). doi: 10.1111/j.1445-5994.2008.01691.x

Stamp, L. K., Easson, A., Highton, J., & Hessian, P. A. (2008). IL-17 gene expression in rheumatoid synovium and nodules. Annals of the Rheumatic Diseases, 67(Suppl. II), (pp. 457). [Abstract]

Drennan, P. G., Troughton, R., Chapman, P. T., O'Donnell, J. L., Richards, A. M., Frampton, C., & Stamp, L. (2008). Determining the association between N terminal pro-brain natriuretic peptide (NT-proBNP) and systemic inflammation in patients with RA. Internal Medicine Journal, 38(Suppl. 2), (pp. A23). doi: 10.1111/j.1445-5994.2008.01691.x

White, D., Chapman, P., O'Donnell, J., James, J., & Stamp, L. (2008). Is an elevated mean red cell volume predictive of haematological toxicity in patients taking methotrexate? Internal Medicine Journal, 38(Suppl. 2), (pp. A28). doi: 10.1111/j.1445-5994.2008.01691.x

Hollis-Moffatt, J. E., Xu, X., Dalbeth, N., Gow, P. J., Harrison, A. A., Highton, J., … Stamp, L. K., & Merriman, T. R. (2008). The urate transporter 1 gene and gout in New Zealand. Rheumatology, 47(Suppl. 2), (pp. ii81-ii82). doi: 10.1093/rheumatology/kem520

Dalrymple, J., Stamp, L. K., O'Donnell, J., Chapman, P., Zhang, M., & Barclay, M. (2008). Pharmacokinetics of oral MTX in RA patients. Arthritis & Rheumatism, 58(Suppl.9), (pp. S311). [Abstract]

Stamp, L. K., O'Donnell, J., Chapman, P., Zhang, M., Frampton, C., & Barclay, M. (2008). Methotrexate polyglutamates and disease activity in rheumatoid arthritis. Arthritis & Rheumatism, 58(Suppl. 9), (pp. S544). [Abstract]

Hessian, P. A., Lehnigk, U., Easson, A., McKelvey, K., Stamp, L., & Highton, J. (2008). Interleukin-17A expression and lymphoid follicle formation in RA synovial membrane. Arthritis & Rheumatism, 58(9, Suppl.), (pp. S285-S286). [Abstract]

Stamp, L. K., Easson, A., Highton, J., & Hessian, P. A. (2008). IL-23/IL-17 axis in rheumatoid synovium: IL-23 is a determinant of synovial IL-17 production. Arthritis & Rheumatism, 58(Suppl. 9), (pp. S187-S188). [Abstract]

Dalbeth, N., Hollis-Moffatt, J. E., Xu, X., Merriman, M., Gow, P., Harrison, A., Highton, J., … Stamp, L. K., & Merriman, T. (2008). The GLUT9 gene and susceptibility to gout in the New Zealand population. Arthritis & Rheumatism, 58(Suppl. 9), (pp. S879). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

White, D. H. N., Chapman, P. T., O'Donnell, J. L., James, J., Frampton, C., & Stamp, L. K. (2008, September). Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving methotrexate for rheumatoid arthritis. Verbal presentation at the New Zealand Rheumatology Association Conference, Hamilton, New Zealand.

Khan, A. R., O'Donnell, J. L., Stamp, L., & Chapman, P. (2008, September). Are crystals enough? Verbal presentation at the New Zealand Rheumatology Association Conference, Hamilton, New Zealand.

Stamp, L. (2008, May). RA/undifferentiated arthritis. Verbal presentation at the 50th Annual Scientific Meeting of the Australian Rheumatology Association, Adelaide, Australia.

2007

Journal - Research Article

Jenks, K. A., Stamp, L. K., O'Donnell, J. L., Savage, R. L., & Chapman, P. T. (2007). Leflunomide-associated infections in rheumatoid arthritis. Journal of Rheumatology, 34, 2201-2203.

Proudman, S. M., Keen, H. I., Stamp, L. K., Lee, A. T. Y., Goldblatt, F., Ayres, O. C., … Cleland, L. G. (2007). Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Seminars in Arthritis & Rheumatism, 37(2), 99-111.

O'Donnell, J. L., Stevanovic, V. R., Frampton, C., Stamp, L. K., & Chapman, P. T. (2007). Wegener's granulomatosis in New Zealand: Evidence for a latitude-dependent incidence gradient. Internal Medicine Journal, 37, 242-246.

Meuli, K., Chapman, P., O'Donnell, J., Frampton, C., & Stamp, L. (2007). Audit of pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5-year period. Internal Medicine Journal, 37, 687-692.

Stamp, L. K., O'Donnell, J. L., & Chapman, P. T. (2007). Emerging therapies in the long-term management of hyperuricaemia and gout. Internal Medicine Journal, 37, 258-266.

Steer, S., Abkevich, V., Gutin, A., Cordell, H. J., Gendall, K. L., Merriman, M. E., Green, R. A., Rowley, K. A., Chapman, P., … Harrison, A. A., Highton, J., … O'Donnell, J., Stamp, L., … Merriman, T. R. (2007). Genomic DNA pooling for whole-genome association scans in complex disease: Empirical demonstration of efficacy in rheumatoid arthritis. Genes & Immunity, 8, 57-68. doi: 10.1038/sj.gene.6364359

O'Donnell, J. L., Hayman, M. W., Spellerberg, M. B., McLellan, A. D., Brooksbank, K., Chapman, P. T., & Stamp, L. K. (2007). Antineutrophil cytoplasmic antibody measurement: Advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA. Pathology, 39(2), 258-263.

Journal - Research Other

Dalbeth, N., & Stamp, L. (2007). Allopurinol dosing in renal impairment: Walking the tightrope between adequate urate lowering and adverse events. Seminars in Dialysis, 20(5), 391-395. doi: 10.1111/j.1525-139X.2007.00270.x

Highton, J., Hessian, P. A., & Stamp, L. (2007). The rheumatoid nodule: Peripheral or central to rheumatoid arthritis? [Editorial]. Rheumatology, 46, 1385-1387.

Journal - Professional & Other Non-Research Articles

Stamp, L. (2007). [Review of the book Joint and soft tissue injection (4th edition): Injecting with confidence]. New Zealand Medical Journal, 120(1263). Retrieved from http://journal.nzma.org.nz/journal/120-1263/2765/content.pdf

Conference Contribution - Published proceedings: Abstract

Stamp, L. K., Easson, A., Highton, J., Koevoet, M., & Hessian, P. A. (2007). Interleukin (IL)-17 in rheumatoid nodules and synovium: Evidence for a difference between the two lesions. Internal Medicine Journal, 37(Suppl. 2), (pp. A54). doi: 10.1111/j.1445-5994.2007.01428.x

Stamp, L., Barclay, M., Zhang, M., James, J., Frampton, C., O'Donnell, J., & Chapman, P. (2007). Red cell folate may be an important determinant of response to methotrexate in rheumatoid arthritis. Internal Medicine Journal, 37(Suppl. 2), (pp. A54). doi: 10.1111/j.1445-5994.2007.01428.x

Meuli, K. A., Stamp, L. K., O'Donnell, J. L., Savage, R. L., & Chapman, P. T. (2007). Leflunomide-associated infections in RA. Internal Medicine Journal. 37(Suppl. 2), (pp. A48). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Phipps-Green, A., Merriman, M., Chapman, P., . . ., Harrison, A., Highton, J., … O'Donnell, J., Stamp, L., & Merriman, T. (2007, August-September). Confirmation of a third locus that confers genetic susceptibility to rheumatoid arthritis. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

McKinney, C., Merriman, M., Chapman, P., . . ., Harrison, A., Highton, J., … O'Donnell, J., Stamp, L., & Merriman, T. (2007, August-September). Low FcγRIIIB copy number is associated with rheumatoid arthritis in a New Zealand cohort. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

Hollis-Moffatt, J., Xu, X., Merriman, M., Chapman, P., Dalbeth, N., Gow, P., Harrison, A., Highton, J., … O'Donnell, J., Stamp, L., & Merriman, T. (2007, August-September). The urate transporter 1 (URAT1) gene and gout in Polynesian New Zealanders. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

Gendall, K., Colgan, Rodger, R., Merriman, M., Chapman, P., . . ., Harrison, A., Highton, J., … O'Donnell, J., Stamp, L., … Merriman, T. (2007, August-September). The BCL2 gene and aetiology of autoimmune disease. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

Merriman, T., Merriman, M., Chapman, P., . . ., Harrison, A., Highton, J., … O'Donnell, J., Stamp, L., & Hollis-Moffatt, J. (2007, August-September). Genetic distinction between rheumatoid arthritis and other auto immune diseases: The Interleukin 23 receptor gene. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

Zhang, M., Moore, G. A., Stamp, L., Barclay, M. L., & Begg, E. J. (2007, August). Rapid and simple HPLC assay for the determination of allopurinol and oxypurinol in human plasma. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (NZ) Annual Scientific Meeting, Auckland, New Zealand.

Stamp, L. K., O'Donnell, J. L., Chapman, P. T., Frampton, C., Barclay, M. L., Kennedy, M., & Roberts, R. L. (2007, August-September). HLA-G 14BP polymorphism is not associated with response to methotrexate in rheumatoid arthritis. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

Dalrymple, J., Barclay, M., Chapman, P., O'Donnell, J., Zhang, M., & Stamp, L. (2007, August-September). The elimination of red blood cell methotrexate polyglutamates in patients with rheumatoid arthritis. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

Stamp, L. K., Easson, A., Lehnigk, U., Koevoet, M., Highton, J., & Hessian, P. A. (2007, August-September). Interleukin -17 in rheumatoid nodules: Evidence for a difference from the synovium. Verbal presentation at the New Zealand Rheumatology Association Conference, Dunedin, New Zealand.

Dalrymple, J. M., Stamp, L. K., Zhang, M., Chapman, P. T., O'Donnell, J. L., & Barclay, M. L. (2007, August). The elimination of red blood cell methotrexate polyglutamates in patients with rheumatoid arthritis. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (NZ) Annual Scientific Meeting, Auckland, New Zealand.

2006

Journal - Research Article

Hayman, M. W., van Beijnen, M. T. A., Stamp, L. K., Spellerberg, M. B., & O'Donnell, J. L. (2006). Soluble human leukocyte antigen: A diagnostic indicator of rheumatoid arthritis? Journal of Immunological Methods, 315, 19-26.

Dalbeth, N., Kumar, S., Stamp, L., & Gow, P. (2006). Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. Journal of Rheumatology, 33(8), 1646-1650.

Stamp, L., Ha, L., Searle, M., O'Donnell, J., Frampton, C., & Chapman, P. (2006). Gout in renal transplant recipients. Nephrology, 11(4), 367-371. doi: 10.1111/j.1440-1797.2006.00577.x

Gibson, A., Stamp, L. K., Chapman, P. T., & O'Donnell, J. L. (2006). The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology, 45, 624-628. doi: 10.1093/rheumatology/kei259

Journal - Research Other

Stamp, L., Roberts, R., Kennedy, M., Barclay, M., O'Donnell, J., & Chapman, P. (2006). The use of low dose methotrexate in rheumatoid arthritis: Are we entering a new era of therapeutic drug monitoring and pharmacogenomics? Biomedicine & Pharmacotherapy, 60, 678-687.

Conference Contribution - Published proceedings: Abstract

Hayman, M. W., Spellerberg, M. B., Brookshank, K., McLellan, A., Chapman, P. T., Stamp, L. K., & O'Donnell, J. L. (2006). Antineutrophil cytoplasmic antibody measurement by capture PR3 Elisa: Advantages and disadvantages. Annals of the Rheumatic Diseases, 65(Supp. II), (pp. 370-371). [Abstract]

Meuli, K. A., Chapman, P. T., O'Donnell, J. L., & Stamp, L. K. (2006). An audit of pneumocystis jiroveci pneumonia in rheumatology patients in the Canterbury region over a 5 year period. Internal Medicine Journal, 36(Suppl. 2), (pp. A85). doi: 10.1111/j.1445-5994.2006.01116.x

O'Donnell, J. L., Stevanovic, V. R., Frampton, C., Stamp, L. K., & Chapman, P. T. (2006). Evidence for a latitudinal gradient in the incidence of Wegener's granulomatosis in the Southern Hemisphere. Annals of the Rheumatic Diseases, 65(Suppl. II), (pp. 375-376). [Abstract]

Hayman, M. W., van Beijnen, M. T. A., Spellerberg, M. B., McLellan, A., Stamp, L. K., & O'Donnell, J. L. (2006). Soluable human leukocyte antigen as a diagnostic marker for rhematoid arthritis. Annals of the Rheumatic Diseases, 65(Suppl. II), (pp. 585). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Stamp, L., Easson, A., Highton, J., & Hessian, P. (2006, December). Interleukin (IL)-17 in rheumatoid nodules and synovium: Evidence for a difference between the two lesions. Poster session presented at the Australasian Society for Immunology Conference.

Conference Contribution - Verbal presentation and other Conference outputs

Highton, J., Harrison, A., and New Zealand Rheumatology Research Network, including Chapman, P., O'Donnell, J., & Stamp, L. (2006, August-September). Rheumatoid arthritis disease activity and change in therapy by NZ rheumatologists. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Meuli, K., Chapman, P., O'Donnell, J., & Stamp, L. (2006, August-September). An audit of pneumocystis pneumonia in rheumatology patients in the Canterbury region over a 5 year period. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Merriman, T., Chapman, P., Gow, P., Harrison, A., Highton, J., . . ., O'Donnell, J., Stamp, L., & et al (2006, August-September). Genomic DNA pooling for whole genome association scans in complex disease: Empirical demonstration of efficacy in rheumatoid arthritis. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Meuli, K., Chapman, P., O'Donnell, J., & Stamp, L. (2006, August-September). PUO in a patient with stable RA. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

O'Donnell, J. L., Stevanovic, V. R., Frampton, C., Stamp, L. K., & Chapman, P. T. (2006, August-September). Evidence for a latitudinal gradient in the incidence of Wegener's granulomatosis in the Southern Hemisphere. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Stamp, L., Highton, J., Easson, A., & Hessian, P. (2006, August-September). IL-17 in rheumatoid nodules: Evidence for a difference from the synovium. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Stamp, L., Ha, L., Chapman, P., O'Donnell, J., & Searle, M. (2006, August-September). The prevalence and management of gout in the renal transplant recipients in Canterbury, New Zealand. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Stamp, L., Dalrymple, J., Barclay, M., Zhang, M., James, J., Frampton, C., Chapman, P., & O'Donnell, J. (2006, August-September). Methotrexate management in rheumatoid arthritis: Is there a role for methotrexate polyglutamate measurement? Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Queenstown, New Zealand.

Dalrymple, J., Barclay, M., Zhang, M., Chapman, P., O'Donnell, J., Frampton, C., & Stamp, L. (2006, November). The pharmacokinetics of accumulation of methotrexate polyglutamates in patients with rheumatoid arthritis. Verbal presentation at the Society of Hospital Pharmacists of Australia 5th Biennial Clinical Conference, Melbourne, Australia.

Dalrymple, J., Barclay, M., Zhang, M., Chapman, P., O'Donnell, J., Frampton, C., & Stamp, L. (2006, August-September). The pharmacokinetics of accumulation of methotrexate polyglutamates in patients with rheumatoid arthritis. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (New Zealand) Annual Scientific Meeting, Auckland, New Zealand.

2005

Journal - Research Article

Stamp, L. K., James, M. J., & Cleland, L. G. (2005). Diet and rheumatoid arthritis: A review of the literature. Seminars in Arthritis & Rheumatism, 35(2), 77-94. doi: 10.1016/j.semarthrit.2005.05.001

Journal - Research Other

Stamp, L., Searle, M., O'Donnell, J., & Chapman, P. (2005). Gout in solid organ transplantation: A challenging clinical problem. Drugs, 65(18), 2593-2611. doi: 10.2165/00003495-200565180-00004

Stamp, L. K., & O'Donnell, J. L. (2005). HLA-B27 associated spondyloarthropathy, vasculitis, and amyloid enteropathy: Response to infliximab. Journal of Rheumatology, 32(2), 382-385.

Stamp, L., Cross, N., & O'Donnell, J. (2005). Weight gain with tumour necrosis factor-α inhibitors [Letter to the editor]. Internal Medicine Journal, 35(4), 267.

Conference Contribution - Published proceedings: Abstract

Zhang, M., Moore, G. A., Barclay, M. L., & Stamp, L. (2005). HPLC assay for erythrocyte methotrexate polyglutamates. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Scientific Meeting. Wellington, New Zealand: ASCEPT. [Abstract]

Gibson, A., Stamp, L. K., Chapman, P. T., & O'Donnell, J. L. (2005). The prevalence and clinical severity of Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) in Canterbury, New Zealand. Internal Medicine Journal, 35(Suppl.), (pp. A93). doi: 10.1111/j.1445-5994.2005.961.x

Conference Contribution - Poster Presentation (not in published proceedings)

Ha, L., Chapman, P., Searle, M., O'Donnell, J., & Stamp, L. (2005, May). Gout in the sold organ transplant population of Canterbury New Zealand. Poster session presented at the 47th Annual Scientific Meeting of the Australian Rheumatology Association, Melbourne, Australia.

Conference Contribution - Verbal presentation and other Conference outputs

Gibson, A. T. P., Chapman, P. T., O'Donnell, J. L., & Stamp, L. (2005, September). A pilot study: Therapeutic drug monitoring of azathioprine in rheumatoid arthritis. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Palmerston North, New Zealand.

Merriman, T., Chapman, P., Gow, P., Harrison, A., Highton, J., . . ., O'Donnell, J., … Stamp, L., & McKinney, C. (2005, September). Genetic causes of rheumatoid arthritis: The chemokine system. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Palmerston North, New Zealand.

Stamp, L., Gibson, A., Chapman, P., & O'Donnell, J. (2005, September). Many causes of a positive ANCA: The Canterbury experience. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Palmerston North, New Zealand.

Chapman, P. T., Stamp, L. K., & O'Donnell, J. L. (2005, September). Anti-TNF therapy in adult rheumatic disease: Christchurch Hospital experience 2002-2005. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Palmerston North, New Zealand.

Dalbeth, N., Kumar, S., Stamp, L., & Gow, P. J. (2005, September). An electronic allopurinol dose calculator in gout: Does ″closing the loop″ on renal dosing provide adequate control of hyperuricaemia? Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Palmerston North, New Zealand.

Zhang, M., Moore, G. A., Barclay, M. L., & Stamp, L. (2005, August). HPLC assay for erythrocyte methotrexate polyglutamates. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Scientific Meeting, Wellington, New Zealand.

2004

Journal - Research Article

Stamp, L. K., James, M. J., & Cleland, L. G. (2004). Interleukin-17: The missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis? Immunology & Cell Biology, 82, 1-9.

Stamp, L. K., Cleland, L. G., & James, M. J. (2004). Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: Role of interleukin 17 and tumor necrosis factor-α. Journal of Rheumatology, 31(7), 1246-1254.

Stamp, L. K., James, M. J., & Cleland, L. G. (2004). Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: Role of interleukin 17 and interferon-γ. Journal of Rheumatology, 31(7), 1255-1264.

Journal - Research Other

Stamp, L. (2004). [Review of the book ABC of rheumatology]. New Zealand Medical Journal, 117(1199). Retrieved from http://journal.nzma.org.nz/journal/117-1199/1009/content.pdf

Conference Contribution - Published proceedings: Abstract

Gibson, A., Stamp, L., Chapman, P. T., & O'Donnell, J. (2004). The five year period prevalence and clinical severity of Wegener's granulomatosis (WG) in the Canterbury, New Zealand. Proceedings of the Annual Scientific Meeting of the New Zealand Rheumatology Association and the New Zealand Health Professionals in Rheumatology. [Abstract]

Awarded Doctoral Degree

Stamp, L. K. (2004). T lymphocyte cyclooxygenase isotypes and the role of T lymphocytes in modulating monocyte and synoviocyte cyclooxygenase expression (PhD). University of Adelaide, Adelaide, Australia. 322p.

2003

Journal - Research Article

Cleland, L. G., Proudman, S. M., Hall, C., Stamp, L., McWilliams, L., Wylie, N., … James, M. (2003). A biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids, 38(4), 419-424.

Conference Contribution - Published proceedings: Abstract

Stamp, L., Cleland, L., & James, M. (2003). Activated T lymphocytes upregulate monocyte COX-2: Role of IL-17 and IFN-gamma. Internal Medicine Journal, 33(Suppl.), (pp. A72). doi: 10.1046/j.1445-5994.2003.t01-6-00001.x

Stamp, L., Cleland, L. G., & James, M. (2003). Up-regulation of synoviocyte COX-2 through interactions with T lymphocytes: Role of IL-17 and TNF-alpha. Internal Medicine Journal, 33(Suppl.), (pp. A90). doi: 10.1046/j.1445-5994.2003.t01-6-00001.x

Stamp, L., Cleland, L., Demasi, M., Spargo, L., & James, M. (2003). Human T cells produce thromboxane and prostaglandins via COX-1 but not COX-2. Internal Medicine Journal, 33(Suppl.), (pp. A11). doi: 10.1046/j.1445-5994.2003.00001.x

Conference Contribution - Verbal presentation and other Conference outputs

Stamp, L., Cleland, L., & James, M. (2003, May). Up-regulation of synoviocyte COX-2 through interactions with T lymphocytes: Role of IL-17 and TNF-alpha. Verbal presentation at the 45th Annual Scientific Meeting of the Australian Rheumatology Association, Sydney, Australia.

2002

Conference Contribution - Poster Presentation (not in published proceedings)

Stamp, L., Cleland, L., Demasi, M., Spargo, L., & James, M. (2002, May). Human T cells produce thromboxane and prostaglandins via COX-1 but not COX-2. Poster session presented at the NZRA and ARA Combined Scientific Conference, Christchurch, New Zealand.

2001

Journal - Research Other

Stamp, L., McLean, L., Stewart, N., & Birdsall, M. (2001). Bilateral transient osteoporosis of the knee in pregnancy. Annals of the Rheumatic Diseases, 60(7), 721-722. doi: 10.1136/ard.60.7.721a

Journal - Professional & Other Non-Research Articles

Cleland, L. G., James, M. J., Stamp, L. K., & Penglis, P. S. (2001). COX-2 inhibition and thrombotic tendency: A need for surveillance. Medical Journal of Australia, 175(4), 214-217.

Conference Contribution - Verbal presentation and other Conference outputs

Stamp, L. (2001, May). A system for treatment and monitoring outcomes in recent onset rheumatoid arthritis. Verbal presentation at the 44th Annual Scientific Conference of the Australian Rheumatology Association, Adelaide, Australia.

2000

Journal - Research Article

Stamp, L., Gow, P., Raill, B., & Sharples, K. (2000). The optimal use of allopurinol: An audit of allopurinol use in South Auckland. Australian & New Zealand Journal of Medicine, 30(5), 567-572. doi: 10.1111/j.1445-5994.2000.tb00857.x

Journal - Research Other

Stamp, L., Lambie, N., & O'Donnell, J. (2000). HLA-B27 associated spondyloarthropathy and severe ascending aortitis. Journal of Rheumatology, 27, 2038-2040.

Conference Contribution - Poster Presentation (not in published proceedings)

Stamp, L. (2000, April). A retrospective review of Y90 synovectomy in Auckland. Poster session presented at the 43rd Annual Scientific Conference of the Australian Rheumatology Association, Hobart, Australia.